<!DOCTYPE html>
<html lang="en" class="scroll-smooth">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Late Night Pyq (Inicet, Pharmacology-1) - Brain And Scalpel</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced & Mobile-First */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

html {
  scroll-behavior: smooth;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
  background-color: #000;
}

/* iOS Background Fix */
body::before {
  content: '';
  position: fixed;
  top: 0;
  left: 0;
  height: 100vh;
  width: 100vw;
  z-index: -2;
  background: url("assets/background.jpg") center center / cover no-repeat;
}

body::after {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
  
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
  
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* --- MOBILE RESPONSIVE STYLES --- */
.quiz-container {
    display: flex;
    flex-direction: column;
    gap: 1.5rem;
}

#mobile-nav-toggle {
    display: none; /* Hidden on desktop */
}

@media (min-width: 1024px) {
    .quiz-container {
        flex-direction: row;
        gap: 2rem;
    }
}

@media (max-width: 1023px) {
    .quiz-sidebar {
        position: fixed;
        top: 0;
        left: 0;
        width: 300px;
        height: 100%;
        z-index: 100;
        transform: translateX(-100%);
        transition: transform 0.3s ease-in-out;
        box-shadow: 10px 0px 30px rgba(0,0,0,0.5);
    }
    .quiz-sidebar.open {
        transform: translateX(0);
    }
    #mobile-nav-toggle {
        display: flex;
        position: fixed;
        bottom: 20px;
        left: 20px;
        z-index: 50;
    }
    .quiz-main-content {
        width: 100%;
    }
}

@media (max-width: 768px) {
    .glass-card, .glass {
        border-radius: 16px;
    }
    h1 { font-size: 2.5rem; }
    #questionText { font-size: 1.125rem; }
    .controls-container {
        flex-direction: column;
        gap: 1rem;
    }
    .controls-container button {
        width: 100%;
    }
}

    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        Cerebellum / Mock Test / Late Night PYQ (INICET)
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">75</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="quiz-container container mx-auto px-6">
        <!-- Question Navigation Sidebar -->
        <div id="quizSidebar" class="quiz-sidebar glass p-6 h-fit lg:sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="quiz-main-content flex-1 max-w-4xl">
            <div class="glass-card p-4 md:p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <div id="solutionAudio" class="space-y-2 mt-4"></div>
                    <div id="solutionImages" class="space-y-4 mt-4"></div>
                    <div id="solutionVideo" class="hidden mt-4">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls>
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="controls-container flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center justify-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd" />
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z" />
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center justify-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

     <!-- Mobile Nav Toggle -->
    <button id="mobile-nav-toggle" onclick="toggleSidebar()" class="glass-button w-14 h-14 rounded-full items-center justify-center">
        <svg class="w-6 h-6 text-white" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
    </button>


    <script>
        let questionsData = [
  {
    "id": 7008,
    "choices": [
      {
        "id": 28000,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">50 mg</span></span></span></p>"
      },
      {
        "id": 28001,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">30.5 mg</span></span></span></p>"
      },
      {
        "id": 28002,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">12.5 mg</span></span></span></p>"
      },
      {
        "id": 28003,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">6.25 mg</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">How much drug will be left after 6 hours if a patient is given a dose of 200 mg and 75 mg is excreted in 90 minutes. (Assume that the drug follows first-order kinetics)? &nbsp;(AIIMS MAY 2017)</span></span></p>",
    "unique_key": "Q7955642",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264291,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:16px\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\">Ans. B. 30.5 mg</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:16px\">This question can be solved by two methods.</span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:16px\"><strong>Method 1: Using the fraction method</strong></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:16px\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\">In 1<sup>st</sup> order kinetics, a constant fraction of the drug is excreted in a given time.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:16px\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\">75 mg is excreted in 90 mins. </span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:16px\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\">Therefore 75/200 = 3/8<sup>th</sup> of the drug is eliminated in 90 minutes.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:16px\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\">Thus after 90 minutes, 1-3/8 = 5/8<sup>th</sup> portion of the drug is left behind.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:16px\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\">6 hours = 4 * 90 minutes.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:16px\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\">Or, in 6 hrs = (5/8) * (5/8) *(5/8)*(5/8)* 200 mg will be left behind</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:16px\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\">= 30.518 mg will be left behind.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:16px\"><strong><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\">Method 2: Using the formula</span></span></strong></span></p>\r\n\r\n<p><span style=\"font-size:16px\">First we need to determine the elimination rate constant (k) and the half-life (t1/2) of the drug. </span></p>\r\n\r\n<p><span style=\"font-size:16px\">We know that 75 mg of the drug is excreted in 90 minutes (1.5 hours). This means that the amount remaining after 1.5 hours is 200 mg - 75 mg = 125 mg.</span></p>\r\n\r\n<p><span style=\"font-size:16px\">First, we can use the formula for first-order kinetics to find k:</span></p>\r\n\r\n<p><span style=\"font-size:16px\">k = {log (C0/Ct)} / t\u200b</span></p>\r\n\r\n<p><span style=\"font-size:16px\">Where:</span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:16px\">C0&nbsp;\u200bis the initial concentration (200 mg)</span></li>\r\n\t<li><span style=\"font-size:16px\">Ct&nbsp;\u200bis the concentration after time t (125 mg)</span></li>\r\n\t<li><span style=\"font-size:16px\">t is the time in hours (1.5 hours)</span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:16px\">k = {log\u2061 (200/125)} / 1.5</span></p>\r\n\r\n<p><span style=\"font-size:16px\">k={log\u2061(1.6)} / 1.5</span></p>\r\n\r\n<p><span style=\"font-size:16px\">k &asymp; 0.470/1.5</span></p>\r\n\r\n<p><span style=\"font-size:16px\">k &asymp; 0.313&nbsp;hr<sup>&minus;1</sup></span></p>\r\n\r\n<p><span style=\"font-size:16px\">Next, we find the half-life using the relationship between k and t1/2:</span></p>\r\n\r\n<p><span style=\"font-size:16px\">t1/2 = 0.693 /k </span></p>\r\n\r\n<p><span style=\"font-size:16px\">t1/2 \u200b= 0.693\u200b/0.313</span></p>\r\n\r\n<p><span style=\"font-size:16px\">t1/2 = 2.21&nbsp;hours</span></p>\r\n\r\n<p><span style=\"font-size:16px\">Now, we need to determine the amount of drug left after 6 hours. We use the first-order kinetics formula:</span></p>\r\n\r\n<p><span style=\"font-size:16px\">Ct = C0 &times; e<sup>&minus;kt</sup></span></p>\r\n\r\n<p><span style=\"font-size:16px\">Where:</span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:16px\">C0&nbsp;is the initial concentration (200 mg)</span></li>\r\n\t<li><span style=\"font-size:16px\">k is the elimination rate constant (0.313 hr^-1)</span></li>\r\n\t<li><span style=\"font-size:16px\">t is the time (6 hours)</span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:16px\">Ct = 200 &times; e<sup>&minus;0.313&times;6</sup></span></p>\r\n\r\n<p><span style=\"font-size:16px\">Ct = 200 &times; e<sup>&minus;1.878</sup></span></p>\r\n\r\n<p><span style=\"font-size:16px\">Ct = 200 &times; 0.153 </span></p>\r\n\r\n<p><span style=\"font-size:16px\">Ct &asymp; 30.5&nbsp;mg</span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>",
    "correct_choice_id": 28001,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7009,
    "choices": [
      {
        "id": 28004,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Amoxicillin</span></span></span></p>"
      },
      {
        "id": 28005,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ciprofloxacin</span></span></span></p>"
      },
      {
        "id": 28006,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ofloxacin</span></span></span></p>"
      },
      {
        "id": 28007,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Erythromycin</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is the most bactericidal anti leprotic drug amongst the given drugs? (AIIMS MAY 2017)</span></span></p>",
    "unique_key": "Q5477125",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264292,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C. Ofloxacin</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In general, Rifampicin is the most potent bactericidal anti leprotic drug.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">But in cases of Rifampicin resistance, we use regimens consisting of Ofloxacin+ Clofazimine + Clarithromycin/Minocycline are used for 24 months.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Out of these, the fluoroquinolone Ofloxacin is the most bactericidal anti leprotic drug.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option</span></strong><span style=\"font-size:12.0pt\"> <strong>A</strong>. <strong>Amoxicillin</strong>: Amoxicillin is a broad-spectrum antibiotic effective against a variety of bacterial infections but is not typically used or effective against Mycobacterium leprae, the bacterium that causes leprosy.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Ciprofloxacin</span></strong><span style=\"font-size:12.0pt\">: Ciprofloxacin is another fluoroquinolone that has broad antibacterial activity, including some activity against Mycobacterium species. However, it is not as potent as Ofloxacin in the treatment of leprosy.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D</span></strong><span style=\"font-size:12.0pt\">. <strong>Erythromycin</strong>: Erythromycin is a macrolide antibiotic that has some activity against Mycobacterium species but is less effective and less commonly used in the treatment of leprosy compared to Other Options: like Rifampicin and Ofloxacin.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ofloxacin is the most bactericidal anti-leprotic drug among the given options, especially used in cases where there is resistance to the standard first-line treatment with Rifampicin.</span></span></p>",
    "correct_choice_id": 28006,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7010,
    "choices": [
      {
        "id": 28008,
        "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PGP stands for permeability glycoprotein</span></span></p>"
      },
      {
        "id": 28009,
        "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Also known as CD243</span></span></p>"
      },
      {
        "id": 28010,
        "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Also known as ABCB1</span></span></p>"
      },
      {
        "id": 28011,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Also known as MDR2</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is not true about P-glycoprotein? (AIIMS MAY 2017)</span></span></p>",
    "unique_key": "Q7416675",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264293,
    "difficulty_level": "difficult",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D. Also known as MDR2 </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Also known as MDR2 is not true about P-glycoprotein. P-glycoprotein is also known as permeability glycoprotein (PGP), CD243, and ATP-binding cassette sub-family B member 1 (ABCB1). MDR2, on the other hand, is a different protein called multidrug resistance protein 2, which is also involved in drug transport.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">P-glycoprotein (PGP) is a well-known membrane protein that functions as a drug transporter. It is involved in the efflux of drugs and other substances from cells, contributing to multidrug resistance.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. PGP stands for permeability glycoprotein</span></strong><span style=\"font-size:12.0pt\">: This is true. P-glycoprotein is indeed referred to as permeability glycoprotein.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Also known as CD243</span></strong><span style=\"font-size:12.0pt\">: This is true. P-glycoprotein is identified as CD243 in the cluster of differentiation nomenclature.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Also known as ABCB1</span></strong><span style=\"font-size:12.0pt\">: This is true. P-glycoprotein is also known as ATP-binding cassette sub-family B member 1 (ABCB1).</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">P-glycoprotein is known as permeability glycoprotein (PGP), CD243, and ABCB1, but it is not referred to as MDR2. MDR2 is a separate protein involved in drug transport.</span></span></p>",
    "correct_choice_id": 28011,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7011,
    "choices": [
      {
        "id": 28012,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Griseofulvin</span></span></span></p>"
      },
      {
        "id": 28013,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Amphotericin B</span></span></span></p>"
      },
      {
        "id": 28014,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ampicillin</span></span></span></p>"
      },
      {
        "id": 28015,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Aspirin</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For which of the following drugs, absorption is increased after a fatty meal? (AIIMS MAY 2017)</span></span></p>",
    "unique_key": "Q7211663",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264294,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Griseofulvin</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Griseofulvin is an antifungal drug that acts by blocking the microtubules. It is given orally, preferably with a fatty meal, which has been found to increase its absorption. This enhancement in absorption is due to the lipophilic nature of griseofulvin, which allows it to dissolve better in the presence of dietary fats, facilitating its uptake in the gastrointestinal tract.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option </span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amphotericin B</span></strong>: Amphotericin B is an antifungal medication primarily administered intravenously due to poor oral absorption. Its absorption is not significantly affected by meals.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option </span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ampicillin</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Ampicillin is an antibiotic that is generally well absorbed on an empty stomach. Food can actually reduce the absorption of ampicillin.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option </span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aspirin</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Aspirin is an anti-inflammatory and antipyretic drug. Its absorption is not significantly increased by fatty meals, although taking it with food can help minimize gastrointestinal side effects.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Drugs whose absorption increase with meals</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Griseofulvin</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Statins</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Halofantrine</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Erlotinib</span></span></span></p>",
    "correct_choice_id": 28012,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6988,
    "choices": [
      {
        "id": 27920,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hypoglycemia</span></span></span></p>"
      },
      {
        "id": 27921,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hypokalemia</span></span></span></p>"
      },
      {
        "id": 27922,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tremors</span></span></span></p>"
      },
      {
        "id": 27923,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tachycardia</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is NOT a side effect of salbutamol?(AIIMS MAY 2018)</span></span></p>",
    "unique_key": "Q6850071",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264295,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Hypoglycemia</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Salbutamol is a &beta;2 receptor agonist that is used as a Short Acting Bronchodilator in the relief of acute exacerbations from asthma.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It can lead to tachycardia (due to stimulation of the &beta;1 receptors at large doses), Hypokalemia and development of tolerance on long term use due to desensitization of its receptors and in large doses can lead to hyperglycemia.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Hypokalemia</span></strong><span style=\"font-size:12.0pt\">: This is a known side effect of salbutamol due to its action on &beta;2 receptors, which increase potassium uptake into cells, resulting in lower serum potassium levels.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Tremors</span></strong><span style=\"font-size:12.0pt\">: These are a common side effect of salbutamol due to &beta;2 receptor stimulation in skeletal muscles, leading to muscle tremors.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Tachycardia</span></strong><span style=\"font-size:12.0pt\">: Salbutamol, especially at higher doses, can stimulate &beta;1 receptors in the heart, leading to an increased heart rate.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Salbutamol can cause hypokalemia, tremors, and tachycardia, but it does not cause hypoglycemia. Instead, it can lead to hyperglycemia due to its effect on glycogenolysis and gluconeogenesis.</span></span></span></p>",
    "correct_choice_id": 27920,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6990,
    "choices": [
      {
        "id": 27928,
        "text": "<p><span style=\"font-size:12.0pt;\">Schedule M drugs</span></p>"
      },
      {
        "id": 27929,
        "text": "<p><span style=\"font-size:12.0pt;\">Schedule H drugs</span></p>"
      },
      {
        "id": 27930,
        "text": "<p><span style=\"font-size:12.0pt;\">Schedule J drugs</span></p>"
      },
      {
        "id": 27931,
        "text": "<p><span style=\"font-size:12.0pt;\">Schedule X drugs</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following drugs should be sold only on prescription from a registered medical practitioner? (AIIMS MAY 2018)</span></p>",
    "unique_key": "Q5233547",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264296,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Schedule H drugs</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Under the \"Drugs and Cosmetics Act,\" certain schedules classify drugs based on various criteria, including the need for prescription, potential for abuse, and manufacturing practices.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Schedule H drugs</strong>: These drugs can only be sold with a prescription from a registered medical practitioner. They are labeled with \"Rx\" written in black color to indicate that they should be dispensed only on prescription.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Schedule M drugs</strong>: These pertain to Good Manufacturing Practices (GMP) for pharmaceuticals and do not indicate a requirement for prescription-based sale.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C</strong>. <strong>Schedule J drugs</strong>: This schedule lists diseases and ailments for which a drug may not claim to prevent or cure. It does not pertain to prescription requirements.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D</strong>. <strong>Schedule X drugs</strong>: These are psychotropic substances with a high potential for abuse and must be sold with a valid prescription. While Schedule X drugs also require a prescription, the question specifically asks about drugs that should be sold only on prescription from a registered medical practitioner, making Schedule H drugs the correct answer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The important schedules under the \u201cDrugs and Cosmetics Act\u201d are:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Schedule H</strong> \u2013 The drugs that can be sold only by prescription where Rx is written in black color.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Schedule H1</strong> \u2013 for antibiotics where Rx is written in red color.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Schedule G</strong> \u2013 Drugs that need labelling as \u201cDangerous to use except under medical supervision.\u201d</span></li><li><span style=\"font-size:12.0pt;\"><strong>Schedule X</strong> \u2013 Psychotropic drugs that have a high abuse liability and are to be sold with a valid prescription only.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Schedule P drug</strong> \u2013 describes the life period of drugs in months (unless otherwise specified) between the date of manufacture and date of expiry.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Schedule M</strong> \u2013 GMP or Good Manufacturing Practices.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Schedule J </strong>- List of diseases and ailments which a drug may not claim to prevent or cure</span></li></ul>",
    "correct_choice_id": 27929,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "CriteriaBased",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6991,
    "choices": [
      {
        "id": 27932,
        "text": "<p><span style=\"font-size:12.0pt;\">Clearance</span></p>"
      },
      {
        "id": 27933,
        "text": "<p><span style=\"font-size:12.0pt;\">Volume of distribution</span></p>"
      },
      {
        "id": 27934,
        "text": "<p><span style=\"font-size:12.0pt;\">Plasma half life</span></p>"
      },
      {
        "id": 27935,
        "text": "<p><span style=\"font-size:12.0pt;\">Bioavailability</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">The loading dose of a drug is governed primarily by? (AIIMS MAY 2018)</span></p>",
    "unique_key": "Q8793618",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264297,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Volume of distribution</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Loading dose = Volume of Distribution * Target plasma concentration.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Loading dose is the high initial dose of the drug that is initially given to cover the distribution so that the desired action can take place. In other words, when the time to reach a steady-state is long, it may be desirable to administer a loading dose that promptly raises the concentration of drug in plasma to the target concentration.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Clearance</strong>: Clearance is a measure of the body's efficiency in eliminating the drug but does not determine the loading dose. It is more relevant to the maintenance dose.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Plasma half-life</strong>: The half-life of a drug determines how long it stays in the body but is not directly used to calculate the loading dose.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Bioavailability</strong>: Bioavailability refers to the fraction of the administered dose that reaches the systemic circulation. While important for understanding the effective dose, it does not govern the calculation of the loading dose.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The loading dose of a drug is primarily governed by its volume of distribution, which helps achieve the desired plasma concentration quickly, especially when the drug has a long half-life.</span></p>",
    "correct_choice_id": 27933,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6992,
    "choices": [
      {
        "id": 27936,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Safety</span></span></span></p>"
      },
      {
        "id": 27937,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Efficacy</span></span></span></p>"
      },
      {
        "id": 27938,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Potency</span></span></span></p>"
      },
      {
        "id": 27939,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Toxicity</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Therapeutic index is used for assessing which of the following factors? (AIIMS MAY 2018)</span></span></span></p>",
    "unique_key": "Q4320258",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264298,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Safety</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Therapeutic Index tells us about the margin of safety for a drug. It is calculated as follows:</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Therapeutic index = TD50/ED50</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">&bull; TD50 (Median toxic dose) = Dose at which there were toxic effects at 50% of the subjects</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">&bull; ED50 (Median effect dose) = Dose required to produce a therapeutic effect in 50% of the individuals.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Efficacy</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Efficacy refers to the maximum effect a drug can produce, regardless of dose. The therapeutic index does not measure this.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Potency</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Potency is the amount of drug needed to produce a given effect. It is not assessed by the therapeutic index.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Toxicity</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: While toxicity is a component of the therapeutic index (TD50), the index itself is used to measure the safety margin rather than toxicity alone.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The therapeutic index is used to assess the safety of a drug, indicating the margin between effective and toxic doses. A higher therapeutic index means a drug is safer, with a lower risk of adverse effects at therapeutic doses.</span></span></span></p>",
    "correct_choice_id": 27936,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6993,
    "choices": [
      {
        "id": 27940,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Bleomycin</span></span></span></p>"
      },
      {
        "id": 27941,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Doxorubicin</span></span></span></p>"
      },
      {
        "id": 27942,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Vincristine</span></span></span></p>"
      },
      {
        "id": 27943,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Minocycline</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following drugs can cause flagellated pigmentation of skin? (</span></span><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">AIIMS MAY 2018)</span></span></p>",
    "unique_key": "Q7779513",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264299,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Bleomycin</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Bleomycin is the chemotherapeutic drug that is known to cause flagellated hyperpigmentation in the skin. Another side effect of Bleomycin is pulmonary fibrosis.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Doxorubicin</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This chemotherapeutic agent is known for causing cardiotoxicity and myelosuppression, but it does not typically cause flagellated pigmentation of the skin.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vincristine</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This drug is associated with neurotoxicity, particularly peripheral neuropathy, but it does not cause flagellated hyperpigmentation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Minocycline</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This antibiotic can cause skin pigmentation, but it is not typically flagellated. The pigmentation with minocycline tends to be more diffuse and can affect the skin, nails, and other tissues.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bleomycin is known to cause flagellated hyperpigmentation of the skin as a unique side effect. It can also cause pulmonary fibrosis, making it important to monitor patients for respiratory symptoms during treatment.</span></span></span></p>",
    "correct_choice_id": 27940,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "DiagnosisBased",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7024,
    "choices": [
      {
        "id": 28064,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">a, b and c</span></span></span></p>"
      },
      {
        "id": 28065,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">d and e</span></span></span></p>"
      },
      {
        "id": 28066,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">a, d and e</span></span></span></p>"
      },
      {
        "id": 28067,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">a, b and d</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Aspirin&nbsp;</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">and phenobarbitone are acidic drugs whereas diazepam is a basic drug. Which of the following statement/s about these drugs is/are true?(AIIMS MAY 2019)</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol style=\"list-style-type:lower-alpha\">\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Aspirin is present mainly in non-ionized form in stomach, hence can be easily absorbed</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Diazepam is mostly absorbed form intestine</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Phenobarbitone can be absorbed from stomach but most of the absorption occurs in small intestine due to its large surface area</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">No drug is absorbed in large intestine due to its very low surface area</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Diseases decreasing the transit time of drugs like diarrhea will increase the drug absorption in small intestine</span></span></span></span></li>\r\n</ol>",
    "unique_key": "Q3523345",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264300,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Ans. </span></span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">A. a, b and c</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Absorption across any membrane depends on lipid solubility. Non-ionized form of drugs is lipid soluble and can easily cross the membranes.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/17/screenshot-2024-07-17-153807.png\" style=\"height:434px; width:1000px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">So, basic drugs like diazepam are absorbed maximally from intestine (option b).</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Acidic drugs although are mainly non-ionized in stomach but are absorbed very less because the gastric emptying time is very small. So, these are quickly transferred to intestine. These become ionized in intestine due to alkaline medium. However, due to their longer time of stay in intestine and very large surface area as compared to stomach even the small amount of their non-ionised form contributes to significant absorption. So, practically every drug (whether acidic or basic) are absorbed more in intestine as compared to stomach.&nbsp;</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Aspirin (acidic drug) &ndash; It is non-ionised in stomach and hence easily absorbed.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Diazepam (basic drug)- It is non-ionised in intestine, hence easily absorbed.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Phenobarbitone (acidic drug)- Any drug is maximally absorbed in intestine due to large surface area of intestine.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Surface area of large intestine is large, so statement (d) is wrong.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Diarrhea decreases the transit time of drug, hence decreases the absorption as the time available for absorption decreases.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<h3><span style=\"font-size:14pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">. This statement is incorrect. The large intestine does have a considerable surface area and can absorb drugs, although to a lesser extent compared to the small intestine.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option E</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">. This statement is also incorrect. Diseases that decrease the transit time, such as diarrhea, reduce the absorption of drugs because the time available for absorption is decreased.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Non-ionized forms of drugs are more lipid-soluble and can cross membranes more easily. Acidic drugs like aspirin and phenobarbitone are primarily non-ionized in the stomach but are absorbed mainly in the intestine due to its large surface area. Basic drugs like diazepam are absorbed maximally from the intestine.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Reference: - KDT 8<sup>TH</sup>/20-21</span></span></strong></span></span></p>",
    "correct_choice_id": 28064,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7025,
    "choices": [
      {
        "id": 28068,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">All are true</span></span></span></p>"
      },
      {
        "id": 28069,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">a, b and c only</span></span></span></p>"
      },
      {
        "id": 28070,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">a and e only</span></span></span></p>"
      },
      {
        "id": 28071,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">a, c and e only</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Mention&nbsp;</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">the true statement/s about digoxin toxicity:(AIIMS MAY 2019)</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol style=\"list-style-type:lower-alpha\">\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Earliest manifestation of digoxin toxicity is gastrointestinal symptoms</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Nonspecific vision changes may be noted in digoxin toxicity</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Early toxicity may not correlate with serum levels</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Neurological symptoms may occur without corresponding cardiovascular changes</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Hypokalemia is associated with increased risk of toxicity</span></span></span></span></li>\r\n</ol>",
    "unique_key": "Q2035042",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264301,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Ans. A. All are true</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Most common and earliest adverse effect of digoxin is nausea and vomiting (option a).</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Most common arrhythmia seen in digoxin overdose is ventricular bigeminy.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Other adverse effects of digoxin include Gynecomastia and Vision defects (initially non-specific and later yellow vision): Option b</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Early toxicity may not correlate with serum levels because Digoxin has very high volume of distribution (~450L); So when digoxin reaches heart the plasma concentration may not be high.: Option c</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Hypokalemia increases the risk of toxicity as the binding site of digoxin and K<sup>+</sup> are same on the Na<sup>+</sup> K<sup>+</sup> pump. So, normally K inhibits the binding of digoxin to Na K pump. When K is less (hypokalemia), binding of digoxin increases and toxicity can result.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">However, Note that Digoxin toxicity causes hyperkalemia (due to inhibition of Na K pump, K<sup>+</sup> cannot enter inside cells and remain in blood, hence hyperkalemia occurs).</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">All statements about digoxin toxicity, including the earliest manifestations, vision changes, correlation with serum levels, neurological symptoms, and the association with hypokalemia, are true.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Reference: - KDT 8<sup>TH</sup>/560</span></span></strong></span></span></p>",
    "correct_choice_id": 28068,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7026,
    "choices": [
      {
        "id": 28072,
        "text": "<p><span style=\"font-size:14.0pt;\">Aminopenicillins</span></p>"
      },
      {
        "id": 28073,
        "text": "<p><span style=\"font-size:14.0pt;\">Aminoglycosides</span></p>"
      },
      {
        "id": 28074,
        "text": "<p><span style=\"font-size:14.0pt;\">Macrolides</span></p>"
      },
      {
        "id": 28075,
        "text": "<p><span style=\"font-size:14.0pt;\">Carbapenems</span></p>"
      }
    ],
    "text": "<p><span style=\"color:#333333;font-size:12pt;\">Clostridium&nbsp;difficile diarrhoea is most commonly associated with? (AIIMS MAY 2019)</span></p>",
    "unique_key": "Q2421635",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264302,
    "difficulty_level": "difficult",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;A. Aminopenicillins</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Clostridium difficile diarrhea is a super-infection also called as Pseudomembranous colitis.</span></li><li><span style=\"font-size:14.0pt;\">Most common cause is 3rd generation Cephalosporins</span></li><li><span style=\"font-size:14.0pt;\">Other causes include Clindamycin, Aminopenicillins (Ampicillin and&nbsp;Amoxycillin), and Fluoroquinolones.</span></li><li><span style=\"font-size:14.0pt;\">DOC for treatment of PMC is fidaxomicin now.</span></li><li><span style=\"font-size:14.0pt;\">Stool transplant can also be done.</span></li><li><span style=\"font-size:14.0pt;\">Monoclonal antibody against toxin of C.difficile is Bezlotoxumab.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Aminoglycosides:</strong>&nbsp;These can also lead to C. difficile diarrhea, but they are less commonly the cause compared to aminopenicillins and third-generation cephalosporins.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Macrolides:</strong>&nbsp;Macrolides are less likely to cause C. difficile diarrhea compared to aminopenicillins, third-generation cephalosporins, clindamycin, and fluoroquinolones.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Carbapenems:</strong>&nbsp;Carbapenems are broad-spectrum antibiotics but are not commonly associated with C. difficile diarrhea. Their impact on the gut flora is less significant in this context compared to aminopenicillins and other antibiotics mentioned.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Clostridium difficile diarrhea, also known as pseudomembranous colitis, is commonly associated with aminopenicillins such as ampicillin and amoxicillin. Treatment includes fidaxomicin and potentially stool transplants, with bezlotoxumab available as a monoclonal antibody against the toxin of C. difficile.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Reference: - KDT 8TH/744</strong></span></p>",
    "correct_choice_id": 28072,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7027,
    "choices": [
      {
        "id": 28076,
        "text": "<p><span style=\"color:#333333;font-size:12pt;\">Chlorthalidone</span></p>"
      },
      {
        "id": 28077,
        "text": "<p><span style=\"color:#333333;font-size:12pt;\">Triamterene</span></p>"
      },
      {
        "id": 28078,
        "text": "<p><span style=\"color:#333333;font-size:12pt;\">Spironolactone</span></p>"
      },
      {
        "id": 28079,
        "text": "<p><span style=\"color:#333333;font-size:12pt;\">Furosemide</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"color:#333333;font-size:12.0pt;\">Preferred&nbsp;drug for the treatment of a 48-year-old man with uncomplicated grade 2 hypertension without any associated co-morbidity is (AIIMS MAY 2019)</span></p>",
    "unique_key": "Q9954479",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264303,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"color:#333333;font-size:12pt;\"><strong>Ans.&nbsp;A. Chlorthalidone</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Chlorthalidone</strong> is a thiazide-like diuretic that is highly effective in lowering blood pressure and is often recommended as the preferred first-line treatment for uncomplicated grade 2 hypertension. It has a longer duration of action compared to other thiazides, such as hydrochlorothiazide, making it particularly effective in managing hypertension over a 24-hour period.</span></li><li><span style=\"color:#333333;font-size:12pt;\">According to ACC Guidelines and JNC 8 Guidelines, the DOC for hypertension is Thiazides (preferred diuretic).</span></li><li><span style=\"color:#333333;font-size:12pt;\">Apart from thiazides, the other first line drugs for hypertension are-</span></li><li><span style=\"color:#333333;font-size:12pt;\">ACE Inhibitors</span></li><li><span style=\"color:#333333;font-size:12pt;\">Angiotensin receptor blockers</span></li><li><span style=\"color:#333333;font-size:12pt;\">Calcium channel blockers</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Triamterene</strong>: This is a potassium-sparing diuretic. It is primarily used in combination with other diuretics to prevent hypokalemia but is not recommended as a first-line treatment for hypertension.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Spironolactone</strong>: Another potassium-sparing diuretic, primarily used in conditions such as heart failure, hyperaldosteronism, and resistant hypertension, not as a first-line treatment for uncomplicated hypertension.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Furosemide</strong>: This is a loop diuretic, which is typically used in conditions such as congestive heart failure, renal insufficiency, and edema. It is not recommended as a first-line treatment for uncomplicated hypertension due to its short duration of action and the potential for significant electrolyte disturbances.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">For the treatment of uncomplicated grade 2 hypertension without any associated comorbidities, thiazide diuretics, particularly chlorthalidone, are the preferred first-line agents according to ACC and JNC 8 guidelines.</span></p><p>&nbsp;</p><p><span style=\"color:#333333;font-size:12pt;\"><strong>Reference: - KDT 8<sup>TH</sup>/615</strong></span></p>",
    "correct_choice_id": 28076,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7028,
    "choices": [
      {
        "id": 28080,
        "text": "<p><span style=\"color:#333333;font-size:12pt;\">1, 2 and 4 are correct</span></p>"
      },
      {
        "id": 28081,
        "text": "<p><span style=\"color:#333333;font-size:12pt;\">1, 2 and 3 are correct</span></p>"
      },
      {
        "id": 28082,
        "text": "<p><span style=\"color:#333333;font-size:12pt;\">Only 4 is correct</span></p>"
      },
      {
        "id": 28083,
        "text": "<p><span style=\"color:#333333;font-size:12pt;\">All are correct</span></p>"
      }
    ],
    "text": "<p><span style=\"color:#333333;font-size:12pt;\">Which of the following is/are adverse effect of SGLT2 inhibitors? (AIIMS MAY 2019)</span></p><p>&nbsp;</p><p><span style=\"color:#333333;font-size:12pt;\">1. Ketoacidosis</span></p><p><span style=\"color:#333333;font-size:12pt;\">2. Urosepsis</span></p><p><span style=\"color:#333333;font-size:12pt;\">3. Fournier\u2019s gangrene</span></p><p><span style=\"color:#333333;font-size:12pt;\">4. Angioedema</span></p>",
    "unique_key": "Q9510598",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264304,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"color:#333333;font-size:16px;\"><strong>Ans.&nbsp;B. 1, 2 and 3 are correct</strong></span></p><p>&nbsp;</p><p><span style=\"color:#333333;font-size:16px;\"><strong>SGLT-2 INHIBITORS</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:#333333;font-size:16px;\">Sodium Glucose Transporter 2 (also called SGLT2)&nbsp; is a transporter for reabsorption of glucose and Na<sup>+</sup>. It is present in PCT of nephrons. Drug inhibiting this transporter are Canagliflozin, Dapagliflozin, Empagliflozin, Ertugliflozin etc.</span></li><li><span style=\"color:#333333;font-size:16px;\">By inhibiting the reabsorption of glucose, these drugs result in glucosuria. This can result in urinary tract infections (including Urosepsis) and genital tract infections like Fournier\u2019s gangrene.</span></li><li><span style=\"color:#333333;font-size:16px;\">If used in type 1 diabetes, these decrease the blood sugar by causing glucosuria. The patient usually decreases the dose of insulin or may altogether stop using insulin as blood sugar levels are within required range. However, type 1 diabetes has absolute insulin deficiency. Insulin not only controls blood sugar but is also required for metabolism of ketone bodies. If the person stops using insulin, it may result in Ketoacidosis. Hence, SGLT-2 inhibitors are contra-indicated in Type 1 diabetes mellitus.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">4. <strong>Angioedema:&nbsp;</strong>Angioedema is not a recognized adverse effect of SGLT2 inhibitors. This condition is more commonly associated with other drug classes, such as ACE inhibitors.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The primary adverse effects of SGLT2 inhibitors include ketoacidosis, urosepsis, and Fournier's gangrene, while angioedema is not associated with these medications.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"color:#333333;font-size:16px;\"><strong>Reference: - KDT 8<sup>TH</sup>/301</strong></span></p>",
    "correct_choice_id": 28081,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7034,
    "choices": [
      {
        "id": 28104,
        "text": "<p><span style=\"font-size:12pt;\">Protects the acid labile drug from gastric acidity</span></p>"
      },
      {
        "id": 28105,
        "text": "<p><span style=\"font-size:12pt;\">Protects the gastric mucosa from irritant effects of certain drugs</span></p>"
      },
      {
        "id": 28106,
        "text": "<p><span style=\"font-size:12pt;\">Prolongs the half-life of the drug</span></p>"
      },
      {
        "id": 28107,
        "text": "<p><span style=\"font-size:12pt;\">Delivers drugs distal to stomach</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Many drugs are given as enteric coated tablets. All of the following are the advantages of enteric coating of drugs EXCEPT? (AIIMS MAY 2020)</span><br>&nbsp;</p>",
    "unique_key": "Q6458337",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264305,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C. Prolongs the half-life of the drug</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Enteric coatings on tablets protect acid-labile drugs from gastric acidity, protect the gastric mucosa from irritant effects, and deliver drugs distal to the stomach. However, they do not prolong the half-life of a drug, which is determined by the drug's metabolism and elimination from the body.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Enteric-coated drugs are designed with a special coating that resists dissolution in the acidic environment of the stomach. This coating dissolves instead in the more alkaline environment of the small intestine. The primary purposes of this enteric coating are:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Protect the acid-labile drug from gastric acidity:&nbsp;</strong>Some drugs are unstable in the acidic environment of the stomach and can be degraded before they have a chance to be absorbed. Enteric coating protects these drugs from the acidic gastric environment, ensuring they reach the intestine, where they can be absorbed effectively.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Protect the gastric mucosa from the irritant effects of certain drugs:&nbsp;</strong>Certain drugs can irritate the gastric mucosa, leading to discomfort or even ulcers. Enteric coating prevents these drugs from being released in the stomach, thereby reducing the risk of gastric irritation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Deliver drugs distal to the stomach:&nbsp;</strong>Enteric coating is also used to ensure that a drug is released in the intestine rather than the stomach, which can be important for drugs that are intended to act in the intestine or are better absorbed from the intestinal lining.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Enteric coating is primarily used to protect acid-labile drugs from gastric acidity, protect the gastric mucosa from irritant effects, and ensure drug delivery distal to the stomach. It does not prolong the half-life of the drug.</span></p>",
    "correct_choice_id": 28106,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7035,
    "choices": [
      {
        "id": 28108,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phenobarbitone</span></span></span></p>"
      },
      {
        "id": 28109,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vigabatrin</span></span></span></p>"
      },
      {
        "id": 28110,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ethosuximide</span></span></span></p>"
      },
      {
        "id": 28111,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Levetiracetam</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient who was on antiepileptics for the management of seizure disorder started&nbsp;</span></span></span><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">having visual disturbance. Evaluation reveals the contraction of the visual field. The drug&nbsp;</span></span></span><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">responsible is likely to be? (AIIMS NOV 2022)</span></span></span></p>",
    "unique_key": "Q4203688",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264306,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Vigabatrin</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vigabatrin is an antiepileptic that works by inhibiting GABA Transaminase. It is used for the treatment of infantile spasms. It is known to cause visual field constriction in some patients. This adverse effect is thought to be due to the drug&#39;s influence on the retina and the central nervous system. Vigabatrin is particularly associated with bilateral concentric visual field constriction, and patients on this medication are often monitored with regular visual field testing.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mnemonic</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/18/screenshot-2024-07-18-100536.png\" style=\"height:254px; width:1000px\" /></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Phenobarbitone:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is a barbiturate used to treat epilepsy, but it is not commonly associated with visual field defects. Its side effects may include sedation, dizziness, and cognitive changes, but not specifically visual disturbances like those described.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Ethosuximide:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Primarily used for absence seizures, ethosuximide is not typically associated with visual field contractions. Its side effects can include gastrointestinal disturbances, drowsiness, and headaches.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Levetiracetam:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Commonly used in various forms of epilepsy, levetiracetam&#39;s side effects can include drowsiness, weakness, and behavioral changes, but it is not commonly associated with significant visual field disturbances.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vigabatrin is an antiepileptic drug associated with visual field contraction, requiring regular monitoring of visual fields in patients receiving this medication.</span></span></span></p>",
    "correct_choice_id": 28109,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7036,
    "choices": [
      {
        "id": 28112,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bradycardia with AV block</span></span></span></p>"
      },
      {
        "id": 28113,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Torsades&rsquo; de pointes</span></span></span></p>"
      },
      {
        "id": 28114,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tachycardia</span></span></span></p>"
      },
      {
        "id": 28115,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ventricular fibrillation</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient was taking metoprolol for hypertension but blood pressure was not controlled. Verapamil was added to the regimen. Which of the following adverse effect is likely to be present with combination? (AIIMS MAY 2020)</span></span></p>",
    "unique_key": "Q1787323",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264307,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. Bradycardia with AV block</span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metoprolol is a beta-blocker that is commonly used to hypertension, heart failure, and arrhythmias. It works by slowing down the heart rate and reducing the heart&#39;s demand for oxygen.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Verapamil, on the other hand, is a calcium channel blocker used for similar indications as metoprolol. It reduces the heart rate and has a negative inotropic effect (reduces the force of heart muscle contraction), and can affect the electrical conduction in the heart.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">When used together, metoprolol and verapamil can have additive effects on the heart rate and atrioventricular (AV) nodal conduction. This can lead to:</span></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bradycardia:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> An abnormally slow heart rate.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">AV block:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> A delay or complete block in the electrical impulse conduction through the AV node of the heart.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Torsades de pointes:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is a specific type of ventricular tachycardia that is not typically associated with the combination of metoprolol and verapamil. It is more often related to medications that prolong the QT interval.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Tachycardia:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is an increased heart rate, which is an unlikely side effect of combining metoprolol and verapamil, as both tend to slow the heart rate.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Ventricular fibrillation:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While this is a serious cardiac arrhythmia, it is not a typical side effect of combining metoprolol and verapamil. It&#39;s more commonly associated with ischemic heart disease or other structural heart problems.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The combination of metoprolol and verapamil can lead to significant bradycardia and AV block due to their additive effects on slowing heart rate and AV nodal conduction.</span></span></span></p>",
    "correct_choice_id": 28112,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7037,
    "choices": [
      {
        "id": 28116,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Erection</span></span></span></span></p>"
      },
      {
        "id": 28117,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ejaculation </span></span></span></span></p>"
      },
      {
        "id": 28118,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Dilation of bronchus </span></span></span></span></p>"
      },
      {
        "id": 28119,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Increased cardiac contractility</span></span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Muscarinic receptor stimulation primarily causes which of the following actions?<strong> </strong></span></span></p>",
    "unique_key": "Q1394081",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264308,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. Erection</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Parasympathetic (muscarinic) stimulation result in erection whereas sympathetic stimulation causes ejaculation.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Parasympathetic system causes bronchoconstriction whereas sympathetic system result in bronchodilation.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increase in cardiac contractility is primarily action of beta 1 receptors of the heart.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mnemonic</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Point and Shoot: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/18/screenshot-2024-07-18-100906.png\" style=\"height:163px; width:1000px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B.</span></strong> <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ejaculation:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ejaculation is primarily mediated by the sympathetic nervous system, not the parasympathetic system. Thus, muscarinic receptor stimulation does not cause ejaculation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Dilation of bronchus</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: The parasympathetic system causes bronchoconstriction. Bronchodilation is mediated by the sympathetic nervous system.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Increased cardiac contractility:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased cardiac contractility is primarily an action of beta-1 adrenergic receptors, which are part of the sympathetic nervous system. Muscarinic receptor stimulation generally results in decreased heart rate and contractility.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Muscarinic receptor stimulation is associated with parasympathetic responses such as erection, while sympathetic stimulation is responsible for ejaculation, bronchodilation, and increased cardiac contractility.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>",
    "correct_choice_id": 28116,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7038,
    "choices": [
      {
        "id": 28120,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oxycodone</span></span></span></p>"
      },
      {
        "id": 28121,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clarithromycin</span></span></span></p>"
      },
      {
        "id": 28122,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adalimumab</span></span></span></p>"
      },
      {
        "id": 28123,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rivoraxaban</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rosuvastatin should not be combined with which of the following drugs? (</span></span>INICET May 2020)</p>",
    "unique_key": "Q9105179",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264309,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Clarithromycin</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Statins are metabolized by CYP3A4 enzyme, which is inhibited by clarithromycin. The plasma levels of statins may rise to high levels if used with clarithromycin, resulting in serious adverse effects like myopathy.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>A</strong>. <strong>Oxycodone: </strong>Oxycodone is an opioid analgesic used for pain management. It does not interact significantly with rosuvastatin and does not affect its metabolism.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>C.</strong> <strong>Adalimumab: </strong>Adalimumab is a monoclonal antibody used to treat autoimmune conditions. It does not interfere with the metabolism of rosuvastatin and therefore is not associated with increased risk of myopathy when used in combination.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>D.</strong> <strong>Rivoraxaban: </strong>Rivaroxaban is an anticoagulant used to prevent and treat blood clots. It does not interact with the metabolism of rosuvastatin and does not pose a risk of increased myopathy.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Drugs increasing the risk of statin induced myopathy are:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amiodarone</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gemfibrozil</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HIV protease inhibitors like saquinavir, ritonavir etc.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clarithromycin</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Itraconazole</span></span></span></li>\r\n</ul>",
    "correct_choice_id": 28121,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6870,
    "choices": [
      {
        "id": 27448,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ciprofloxacin and tinidazole </span></span></span></p>"
      },
      {
        "id": 27449,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Only ciprofloxacin</span></span></span></p>"
      },
      {
        "id": 27450,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Only ORS</span></span></span></p>"
      },
      {
        "id": 27451,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ciprofloxacin, tinidazole and ORS</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A young male developed 5 episodes of loose stools 2 hours after eating in a restaurant. He is afebrile and has mild dehydration. What should be the treatment? (AIIMS NOV 2017)</span></span></p>",
    "unique_key": "Q4390879",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264310,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C. Only ORS</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Management of diarrhea in an afebrile patient is mainly based on the presence or absence of dehydration. In case of no dehydration or some dehydration, we can manage it using only ORS. If there is severe dehydration, then IV fluids have to be used. There is no role of antibiotics in such case. Empirical antibiotics are used only in case of febrile patients. If only bacterial etiology is suspected, the Ciprofloxacin is used, and it amoebiasis or giardiasis is suspected, then Metronidazole is used.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Ciprofloxacin and tinidazole: </span></strong><span style=\"font-size:12.0pt\">This combination is used for treating bacterial and protozoal infections. However, it is not indicated here because the patient is afebrile and the condition is likely self-limiting.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Only ciprofloxacin: </span></strong><span style=\"font-size:12.0pt\">Ciprofloxacin is an antibiotic used for bacterial infections. Since the patient is afebrile and has mild dehydration, there is no indication for antibiotic therapy. ORS alone is sufficient.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Ciprofloxacin, tinidazole and ORS: </span></strong><span style=\"font-size:12.0pt\">This combination is unnecessary and potentially harmful. Overuse of antibiotics can lead to resistance and other side effects. The primary treatment needed is rehydration with ORS</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">For a young male with afebrile, mild dehydration due to acute diarrhea, the appropriate treatment is oral rehydration solution (ORS) to replace lost fluids and electrolytes. Antibiotics are not indicated unless there is a suspicion of bacterial infection with severe symptoms or fever.</span></span></span></p>",
    "correct_choice_id": 27450,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6873,
    "choices": [
      {
        "id": 27460,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Baygon</span></span></span></p>"
      },
      {
        "id": 27461,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">TIK 20</span></span></span></p>"
      },
      {
        "id": 27462,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Parathion</span></span></span></p>"
      },
      {
        "id": 27463,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Endrin</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Atropine is indicated in all of the following poisonings except? (AIIMS NOV 2017)</span></span></p>",
    "unique_key": "Q9502634",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264311,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D. Endrin</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Atropine is an anticholinergic agent used to counteract the effects of excessive acetylcholine, such as those seen in organophosphate and carbamate poisoning. It works by blocking the action of acetylcholine on muscarinic receptors, thereby alleviating symptoms of excessive cholinergic activity like salivation, lacrimation, urination, defecation, gastrointestinal distress, and emesis (SLUDGE syndrome).</span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Endrin is an organochloride pesticide, primarily causing neurotoxic effects, including seizures. The mechanism of toxicity involves disruption of the central nervous system rather than the cholinergic system. Therefore, atropine is not effective in managing Endrin poisoning.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Baygon:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Atropine is indicated as it counters the acetylcholine accumulation due to acetylcholinesterase inhibition caused by organophosphates/carbamates in Baygon.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. TIK 20:&nbsp;</span></strong><span style=\"font-size:12.0pt\">As an organophosphate, TIK 20 poisoning results in excessive acetylcholine, where atropine is beneficial.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Parathion:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Parathion is an organophosphate pesticide causing acetylcholinesterase inhibition, making atropine an effective treatment.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Endrin is an organochloride pesticide. It leads to neurotoxicity, and in that case, Atropine cannot be used in the treatment. Parathion and TIK20 are organophosphates and baygon is a combination of organophosphate and carbamate. For all of these poisonings, atropine is the mainstay of management.</span></span></span></p>",
    "correct_choice_id": 27463,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6875,
    "choices": [
      {
        "id": 27468,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hyperprolactinemia</span></span></span></p>"
      },
      {
        "id": 27469,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">PCOD</span></span></span></p>"
      },
      {
        "id": 27470,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hypogonadotrophic hypogonadism</span></span></span></p>"
      },
      {
        "id": 27471,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">PID</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 27-year-old female came for treatment of infertility to OPD, Bromocriptine was prescribed. What could be the possible reason? (AIIMS NOV 2017)</span></span></p>",
    "unique_key": "Q9960925",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264312,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Hyperprolactinemia</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Bromocriptine is a dopamine agonist that acts on D2 receptors. It is effective in reducing prolactin secretion, which is useful in treating hyperprolactinemia. Elevated levels of prolactin can inhibit the secretion of gonadotropin-releasing hormone (GnRH), leading to decreased levels of follicle-stimulating hormone (FSH) and luteinizing hormone (LH), which can cause anovulation and infertility.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Mechanism of Bromocriptine:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Action:</span></strong><span style=\"font-size:12.0pt\"> Bromocriptine stimulates D2 dopamine receptors.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Effect:</span></strong><span style=\"font-size:12.0pt\"> Decreases prolactin secretion from the pituitary gland.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Result:</span></strong><span style=\"font-size:12.0pt\"> Reduction in prolactin levels can restore normal GnRH secretion, normalizing FSH and LH levels and resuming ovulatory cycles, thus addressing infertility.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. PCOD (Polycystic Ovarian Disease):&nbsp;</span></strong><span style=\"font-size:12.0pt\">PCOD is characterized by multiple cysts in the ovaries, insulin resistance, and hyperandrogenism. Treatment usually involves lifestyle changes, metformin, or hormonal therapies, not specifically bromocriptine unless associated with hyperprolactinemia.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Hypogonadotrophic hypogonadism:&nbsp;</span></strong><span style=\"font-size:12.0pt\">This condition involves low levels of FSH and LH due to hypothalamic or pituitary dysfunction. Treatment often includes gonadotropins or pulsatile GnRH therapy. Bromocriptine is not indicated unless hyperprolactinemia is a contributing factor.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. PID (Pelvic Inflammatory Disease):&nbsp;</span></strong><span style=\"font-size:12.0pt\">PID is an infection of the female reproductive organs. Treatment typically involves antibiotics. Bromocriptine has no role in treating PID.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Bromocriptine is a Dopaminergic agonist that leads to a decrease in the secretion of Prolactin by its action on the D2 dopaminergic receptors of the Nigrostriatal Pathway. Hyperprolactinemia can cause infertility by inhibiting the release of GnRH from the hypothalamus, leading to a decrease in the levels of FSH and LH.</span></span></span></p>",
    "correct_choice_id": 27468,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6876,
    "choices": [
      {
        "id": 27472,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Carbamazepine</span></span></span></p>"
      },
      {
        "id": 27473,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lamotrigine</span></span></span></p>"
      },
      {
        "id": 27474,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lithium</span></span></span></p>"
      },
      {
        "id": 27475,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Valproate</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which is a mood stabilizer with an anti-suicidal role? (AIIMS NOV 2017)</span></span></span></p>",
    "unique_key": "Q7540439",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264313,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C. Lithium</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lithium is the only mood stabilizer that has been consistently shown to have an anti-suicidal effect in patients with bipolar disorder and major depressive disorder. Numerous studies have demonstrated that lithium reduces the risk of suicide and suicide attempts. It is considered the gold standard for mood stabilization, particularly in bipolar disorder, due to its efficacy in preventing both manic and depressive episodes.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Mechanism of Lithium:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Mood Stabilization:</span></strong><span style=\"font-size:12.0pt\"> Lithium modulates neurotransmission by affecting various neurotransmitter pathways, including serotonin and norepinephrine.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Neuroprotective Effects:</span></strong><span style=\"font-size:12.0pt\"> Lithium enhances neurogenesis and has neuroprotective effects, potentially contributing to its anti-suicidal properties.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Reduction in Aggression and Impulsivity:</span></strong><span style=\"font-size:12.0pt\"> Lithium has been shown to reduce aggression and impulsivity, which are risk factors for suicide.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Carbamazepine:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Carbamazepine is an anticonvulsant and mood stabilizer used to treat bipolar disorder, particularly in patients with rapid cycling or mixed states. However, it does not have a proven anti-suicidal effect.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Lamotrigine:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Lamotrigine is effective as a mood stabilizer, particularly in preventing depressive episodes in bipolar disorder. While it helps in mood stabilization, it does not have a specific anti-suicidal effect.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Valproate:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Valproate is another anticonvulsant and mood stabilizer used in bipolar disorder, especially effective in rapid cyclers. It does not have an established anti-suicidal role.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lithium is unique among mood stabilizers for its anti-suicidal properties. It significantly reduces the risk of suicide and is effective in stabilizing mood in patients with bipolar disorder and major depressive disorder. </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Valproate is the drug of choice in rapid cyclers, whereas Lamotrigine is effective as a mood stabilizer in Depression.</span></span></span></p>",
    "correct_choice_id": 27474,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6884,
    "choices": [
      {
        "id": 27504,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Blurred vision</span></span></span></p>"
      },
      {
        "id": 27505,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Agranulocytosis</span></span></span></p>"
      },
      {
        "id": 27506,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Rash</span></span></span></p>"
      },
      {
        "id": 27507,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Steven Johnson Syndrome</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is not an idiosyncratic reaction of carbamazepine?</span></span></p>",
    "unique_key": "Q5553376",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264314,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Blurred vision</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Idiosyncrasy is defined as a genetically determined abnormal reactivity to a drug. The drug interacts with some unique feature of the individual, not found in majority of the subjects and produces uncharacteristic reactions. As such the type of the reaction is restricted to individuals with a particular genotype.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Idiosyncratic Reactions of Carbamazepine:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Agranulocytosis:</span></strong><span style=\"font-size:12.0pt\"> This is a serious idiosyncratic reaction where the drug causes a significant drop in white blood cells, particularly neutrophils, leading to a higher risk of infection.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Rash:</span></strong><span style=\"font-size:12.0pt\"> Skin reactions, including rashes, are common idiosyncratic reactions to carbamazepine. These can range from mild to severe.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Steven Johnson Syndrome (SJS):</span></strong><span style=\"font-size:12.0pt\"> Although rare, carbamazepine can cause severe skin reactions like SJS, which is a serious condition involving the skin and mucous membranes and requires immediate medical attention.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Non-Idiosyncratic Reactions:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Blurred Vision:</span></strong><span style=\"font-size:12.0pt\"> This is a common side effect of carbamazepine related to its pharmacological action and dose rather than an idiosyncratic reaction. Blurred vision typically occurs due to the drug&#39;s effects on the central nervous system and is not unique to specific individuals based on genetic or other idiosyncratic factors.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Agranulocytosis:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Agranulocytosis is a potentially life-threatening idiosyncratic reaction associated with carbamazepine, characterized by a significant reduction in granulocytes, a type of white blood cell.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Rash:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Skin rashes are common idiosyncratic reactions to carbamazepine and can vary in severity from mild to severe.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Steven Johnson Syndrome:&nbsp;</span></strong><span style=\"font-size:12.0pt\">SJS is a rare but severe idiosyncratic reaction to carbamazepine, involving extensive skin and mucous membrane damage.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Blurred vision is not an idiosyncratic reaction of carbamazepine; it is a common dose-related side effect. Idiosyncratic reactions to carbamazepine include agranulocytosis, rash, and Steven Johnson Syndrome, which are unpredictable and occur due to individual genetic predispositions.</span></span></span></p>",
    "correct_choice_id": 27504,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6927,
    "choices": [
      {
        "id": 27676,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Primaquine</span></span></span></p>"
      },
      {
        "id": 27677,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chloroquine</span></span></span></p>"
      },
      {
        "id": 27678,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Quinine</span></span></span></p>"
      },
      {
        "id": 27679,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">D None</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is gametocidal to all the species causing malaria? (AIIMS NOV 2018)</span></span></p>",
    "unique_key": "Q8283134",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264315,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>Primaquine</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Primaquine is gametocidal to all species causing malaria. It inhibits transmission of malaria. Artemisinin also have high gametocidal activity against all the species.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Mechanism of Action:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Primaquine interferes with the mitochondrial electron transport chain in the parasite, leading to the death of gametocytes and hypnozoites (dormant liver forms in Plasmodium vivax and Plasmodium ovale).</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">By eliminating gametocytes, primaquine helps reduce the spread of malaria within a community.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Chloroquine:</span></strong><span style=\"font-size:12.0pt\"> is primarily effective against the erythrocytic forms of Plasmodium species but does not have gametocidal activity against all species. It is not effective against the dormant liver forms or the gametocytes of Plasmodium falciparum.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Quinine:</span></strong><span style=\"font-size:12.0pt\"> is effective against the asexual blood stages of Plasmodium species but lacks significant activity against the gametocytes of Plasmodium falciparum. It does not have a broad gametocidal effect against all species.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Primaquine is the antimalarial drug that is gametocidal to all Plasmodium species, making it essential for preventing the transmission of malaria and addressing relapses in cases of Plasmodium vivax and Plasmodium ovale infections.</span></span></span></p>",
    "correct_choice_id": 27676,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6929,
    "choices": [
      {
        "id": 27684,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">- 2 degree Celsius</span></span></span></p>"
      },
      {
        "id": 27685,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">0 degree Celsius</span></span></span></p>"
      },
      {
        "id": 27686,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">2-6 degree Celsius</span></span></span></p>"
      },
      {
        "id": 27687,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">8-15 degree Celsius</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A drug label suggests storage in a &#39;cool&#39; place. What is the temperature at which this drug is to be stored? (AIIMS NOV 2018)</span></span></span></p>",
    "unique_key": "Q9829019",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264316,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D. 8-15 degree Celsius</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">When a drug label suggests storing the medication in a &#39;cool&#39; place, it refers to a specific temperature range to ensure the drug&#39;s stability and efficacy. According to standard pharmaceutical guidelines:</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Cool Place</span></strong><span style=\"font-size:12.0pt\">: This term specifically means storing the drug at a temperature range of 8-15 degrees Celsius. This temperature range helps to preserve the drug&#39;s properties without freezing it or exposing it to room temperature, which could lead to degradation.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. -2 degrees Celsius:&nbsp;</span></strong><span style=\"font-size:12.0pt\">This temperature range is considered freezing. Storing drugs at this temperature could cause them to freeze, which is inappropriate for many medications unless specifically indicated.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. 0 degrees Celsius:&nbsp;</span></strong><span style=\"font-size:12.0pt\">This temperature is the freezing point of water and is also considered freezing storage, which is not suitable for most medications unless specified.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. 2-6 degrees Celsius:&nbsp;</span></strong><span style=\"font-size:12.0pt\">This range is typically referred to as refrigeration. While some drugs need to be stored in a refrigerator, &#39;cool place&#39; storage does not imply refrigeration but rather a slightly warmer range than typical refrigeration.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Drugs labeled to be stored in a &#39;cool&#39; place should be kept at a temperature of 8-15 degrees Celsius to ensure their stability and effectiveness. This is neither freezing nor typical room temperature, but a moderate cool environment.</span></span></span></p>",
    "correct_choice_id": 27687,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6930,
    "choices": [
      {
        "id": 27688,
        "text": "<p><span style=\"font-size:12.0pt;\">Ketoconazole</span></p>"
      },
      {
        "id": 27689,
        "text": "<p><span style=\"font-size:12.0pt;\">Indinavir</span></p>"
      },
      {
        "id": 27690,
        "text": "<p><span style=\"font-size:12.0pt;\">Lamivudine</span></p>"
      },
      {
        "id": 27691,
        "text": "<p><span style=\"font-size:12.0pt;\">Zidovudine</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A patient with AIDS was treated with zidovudine, lamivudine, indinavir, ketoconazole and cotrimoxazole. He developed nephrolithiasis, central obesity, hyperlipidemia and insulin resistance. Which of the drugs could have been the cause? (AIIMS NOV 2018)</span></p>",
    "unique_key": "Q8894092",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264317,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Indinavir</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Indinavir is a protease inhibitor used in the treatment of HIV/AIDS. It is known for several side effects, which include nephrolithiasis (kidney stones), central obesity, hyperlipidemia, and insulin resistance. These adverse effects are part of the metabolic complications often associated with protease inhibitors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Ketoconazole:&nbsp;</strong>Ketoconazole is an antifungal agent that does not typically cause nephrolithiasis, central obesity, hyperlipidemia, or insulin resistance. Its side effects are more related to hepatotoxicity, adrenal insufficiency, and drug interactions due to CYP3A4 inhibition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Lamivudine:&nbsp;</strong>Lamivudine is a nucleoside reverse transcriptase inhibitor (NRTI) used in the treatment of HIV/AIDS. It is not commonly associated with nephrolithiasis, central obesity, hyperlipidemia, or insulin resistance. Its side effects can include lactic acidosis and hepatic steatosis, but these are less common.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Zidovudine:&nbsp;</strong>Zidovudine, another NRTI, is associated with side effects such as anemia, neutropenia, and myopathy but not with the specific metabolic complications listed (nephrolithiasis, central obesity, hyperlipidemia, insulin resistance).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Indinavir, a protease inhibitor used in HIV/AIDS treatment, is the drug responsible for causing nephrolithiasis, central obesity, hyperlipidemia, and insulin resistance among the medications listed.</span></p>",
    "correct_choice_id": 27689,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6932,
    "choices": [
      {
        "id": 27696,
        "text": "<p><span style=\"font-size:12.0pt;\">Pancreatitis</span></p>"
      },
      {
        "id": 27697,
        "text": "<p><span style=\"font-size:12.0pt;\">Thrombocytopenia</span></p>"
      },
      {
        "id": 27698,
        "text": "<p><span style=\"font-size:12.0pt;\">Hepatotoxicity</span></p>"
      },
      {
        "id": 27699,
        "text": "<p><span style=\"font-size:12.0pt;\">Hyperammonemia</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">If carbamazepine is added to ongoing valproate therapy, what adverse effect is risked?</span></p>",
    "unique_key": "Q4983547",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264318,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Hepatotoxicity</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">Valproate is metabolized by CYP450 enzymes into a minor metabolite, which is hepatotoxic.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Enzyme inducers like carbamazepine phenytoin and Phenobarbital can induce the microsomal enzyme and increase production of this metabolite. This increases the risk of hepatotoxicity.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Pancreatitis:&nbsp;</strong>While valproate is associated with a risk of pancreatitis, the addition of carbamazepine does not specifically increase this risk. Pancreatitis is a rare but serious side effect of valproate alone.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Thrombocytopenia:&nbsp;</strong>Thrombocytopenia can be a side effect of valproate, but it is not specifically increased by the addition of carbamazepine. Thrombocytopenia results from bone marrow suppression, which is not directly affected by carbamazepine.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Hyperammonemia:&nbsp;</strong>Hyperammonemia is a known side effect of valproate and can lead to encephalopathy. However, carbamazepine does not exacerbate this condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">When carbamazepine is added to ongoing valproate therapy, there is an increased risk of hepatotoxicity due to the induction of cytochrome P450 enzymes by carbamazepine, leading to increased production of a hepatotoxic metabolite of valproate.</span></p>",
    "correct_choice_id": 27698,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6934,
    "choices": [
      {
        "id": 27704,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cell wall synthesis inhibitor</span></span></span></p>"
      },
      {
        "id": 27705,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Folic acid synthesis inhibitor</span></span></span></p>"
      },
      {
        "id": 27706,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Protein synthesis inhibitor</span></span></span></p>"
      },
      {
        "id": 27707,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cell membrane inhibitor</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is the mechanism of action of dapsone, considering that it is used in the treatment of leprosy, fungal infections and, also for immunomodulatory actions?</span></span></p>",
    "unique_key": "Q8282897",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264319,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B. Folic acid synthesis inhibitor</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Dapsone is a sulfone antibiotic that works by inhibiting the enzyme dihydropteroate synthase. This enzyme is crucial for the synthesis of dihydropteroic acid, a precursor in the folic acid synthesis pathway. By competitively inhibiting dihydropteroate synthase, dapsone prevents the formation of dihydropteroic acid from para-aminobenzoic acid (PABA) and pteridine, ultimately disrupting the production of folic acid, which is essential for bacterial growth and replication.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This mechanism makes dapsone effective in the treatment of leprosy caused by <em>Mycobacterium leprae</em> and also contributes to its use in certain fungal infections and its immunomodulatory actions, such as in the treatment of dermatitis herpetiformis.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Cell wall synthesis inhibitor:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Drugs that inhibit cell wall synthesis, such as penicillin&rsquo;s and cephalosporins, target the synthesis of peptidoglycan, an essential component of bacterial cell walls. Dapsone does not act via this mechanism.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Protein synthesis inhibitor:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Protein synthesis inhibitors, such as tetracyclines and macrolides, interfere with the bacterial ribosome&#39;s ability to produce proteins. Dapsone does not inhibit protein synthesis.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Cell membrane inhibitor:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Drugs like polymyxins disrupt bacterial cell membranes, leading to cell death. Dapsone does not affect the cell membrane.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dapsone is a competitive inhibitor of Dihydropteroate synthase that is required in the step of conversion of PABA + Pteridine into Dihydropteroic acid, which is the first step in the synthesis of folic acid.</span></span></span></p>",
    "correct_choice_id": 27705,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6903,
    "choices": [
      {
        "id": 27580,
        "text": "<p><span style=\"font-size:12.0pt;\">1:10000 I.V. - 10 ml</span></p>"
      },
      {
        "id": 27581,
        "text": "<p><span style=\"font-size:12.0pt;\">1:1000 I.M. - 0.5 ml</span></p>"
      },
      {
        "id": 27582,
        "text": "<p><span style=\"font-size:12.0pt;\">1:1000 I.M. - 1 ml</span></p>"
      },
      {
        "id": 27583,
        "text": "<p><span style=\"font-size:12.0pt;\">1:1000 I.V. - 0.5 ml</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">What dose of epinephrine is used in anaphylactic shock? (AIIMS NOV 2019)</span></p>",
    "unique_key": "Q5093771",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264320,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. 1:1000 I.M. - 0.5 ml</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Epinephrine (1:1000 solution) 0.5 ml via intramuscular route is preferred in the treatment of anaphylactic shock.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/20/screenshot-2023-12-20-103204.jpg\" alt=\"\" width=\"1000\" height=\"398\"></span></p>",
    "correct_choice_id": 27581,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6904,
    "choices": [
      {
        "id": 27584,
        "text": "<p><span style=\"font-size:12.0pt;\">Serotonin and nor-adrenaline reuptake inhibition</span></p>"
      },
      {
        "id": 27585,
        "text": "<p><span style=\"font-size:12.0pt;\">Anticholinergic</span></p>"
      },
      {
        "id": 27586,
        "text": "<p><span style=\"font-size:12.0pt;\">Antihistaminic</span></p>"
      },
      {
        "id": 27587,
        "text": "<p><span style=\"font-size:12.0pt;\">Serotonin and dopamine reuptake inhibition</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"color:#333333;font-size:12pt;\">Like all the opioids, tramadol acts as an analgesic drug by stimulating mu opioid receptors. Apart from this, the additional analgesic mechanism of tramadol is? (AIIMS NOV 2019)</span></p>",
    "unique_key": "Q8312781",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264321,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"color:#333333;font-size:12pt;\"><strong>Ans. A. Serotonin and nor-adrenaline reuptake inhibition</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Tramadol is an atypical opioid analgesic that not only acts by stimulating mu opioid receptors, like other opioids, but also has an additional mechanism of action. This dual mechanism contributes to its analgesic effect.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Mu Opioid Receptor Agonism</strong>: Tramadol binds to mu opioid receptors, which are part of the body's endogenous pain relief system. Activation of these receptors leads to pain relief.</span></li><li><span style=\"font-size:12pt;\"><strong>Serotonin and Noradrenaline Reuptake Inhibition</strong>: Unlike typical opioids, tramadol also inhibits the reuptake of serotonin (5-HT) and noradrenaline (NA). This increases the levels of these neurotransmitters in the synaptic cleft, enhancing their action. This mechanism activates the monoaminergic descending inhibitory pathways in the spinal cord, which further contributes to pain relief.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Due to its unique mechanism, tramadol's analgesic action is only partially reversed by naloxone, an opioid antagonist, indicating that non-opioid mechanisms also play a significant role in its pain-relieving effects.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Anticholinergic:&nbsp;</strong>Tramadol does not have anticholinergic properties. Anticholinergic drugs block the action of acetylcholine in the brain and are not related to the analgesic mechanism of tramadol.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Antihistaminic:&nbsp;</strong>Tramadol does not act as an antihistamine. Antihistamines are used primarily to treat allergic reactions and have no significant role in pain relief through histamine receptor antagonism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Serotonin and dopamine reuptake inhibition:&nbsp;</strong>While tramadol does inhibit serotonin reuptake, it does not inhibit dopamine reuptake significantly. Its main additional mechanism of analgesia is through the inhibition of serotonin and noradrenaline reuptake.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Tramadol provides pain relief not only through mu opioid receptor agonism but also by inhibiting the reuptake of serotonin and noradrenaline, thereby activating the descending inhibitory pain pathways in the spinal cord.</span></p><p>&nbsp;</p><p><span style=\"color:#333333;font-size:12pt;\"><strong>Reference: KDT 8th/504</strong></span></p>",
    "correct_choice_id": 27584,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6906,
    "choices": [
      {
        "id": 27592,
        "text": "<p><span style=\"font-size:12.0pt;\">Endometriosis</span></p>"
      },
      {
        "id": 27593,
        "text": "<p><span style=\"font-size:12.0pt;\">Male infertility</span></p>"
      },
      {
        "id": 27594,
        "text": "<p><span style=\"font-size:12.0pt;\">Central precocious puberty</span></p>"
      },
      {
        "id": 27595,
        "text": "<p><span style=\"font-size:12.0pt;\">Prostate cancer</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"color:#333333;font-size:12pt;\">Non-pulsatile dose of GnRH agonist is used in all of the following conditions except? (AIIMS NOV 2019)</span></p>",
    "unique_key": "Q7178981",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264322,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"color:#333333;font-size:12pt;\"><strong>Ans. B. Male infertility</strong></span></p><p>&nbsp;</p><p><span style=\"color:#333333;font-size:12pt;\">Pulsatile exposure to GnRH induces FSH/LH secretion while sustained exposure de-sensitizes the receptors resulting in decrease in secretion of gonadotropins. Therefore, non-pulsatile (continuous) GnRH agonists are given when we want to decrease the sex hormones.</span></p><p>&nbsp;</p><p><span style=\"color:#333333;font-size:12pt;\"><strong>Indications:-</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:#333333;font-size:12pt;\">&nbsp;Prostatic carcinoma</span></li><li><span style=\"color:#333333;font-size:12pt;\">&nbsp;Endometriosis</span></li><li><span style=\"color:#333333;font-size:12pt;\">&nbsp;Precocious puberty</span></li><li><span style=\"color:#333333;font-size:12pt;\">&nbsp;Fibroid</span></li></ul><p>&nbsp;</p><p><span style=\"color:#333333;font-size:12pt;\">But in case of male infertility, more testosterone is required to induce spermatogenesis, so GnRH agonists are given in pulsatile manner.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Endometriosis:&nbsp;</strong>In endometriosis, continuous GnRH agonists are used to lower estrogen levels, which helps reduce the growth of endometrial tissue and alleviate symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Central precocious puberty</strong></span><span style=\"font-size:12pt;\"><strong>:</strong></span><span style=\"font-size:14px;\"><strong>&nbsp;</strong></span><span style=\"font-size:12pt;\">Continuous GnRH agonists are used to decrease sex hormone levels, thereby delaying early onset puberty.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Prostate cancer:&nbsp;</strong>Continuous GnRH agonists reduce testosterone levels, which helps in managing prostate cancer by slowing down the growth of cancer cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Non-pulsatile (continuous) GnRH agonists are used to decrease sex hormone levels in conditions such as endometriosis, central precocious puberty, and prostate cancer. In male infertility, pulsatile GnRH agonists are used to increase testosterone and induce spermatogenesis.</span></p><p>&nbsp;</p><p><span style=\"color:#333333;font-size:12pt;\"><strong>Reference: KDT 8th/. 262,263</strong></span></p>",
    "correct_choice_id": 27593,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6909,
    "choices": [
      {
        "id": 27604,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Mannitol</span></span></span></p>"
      },
      {
        "id": 27605,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Methazolamide</span></span></span></p>"
      },
      {
        "id": 27606,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Clonidine</span></span></span></p>"
      },
      {
        "id": 27607,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dexamethasone</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">A</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">ll of the following can be used to decreased intraocular pressure in glaucoma except? (</span></span></span></span><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">AIIMS NOV 2019)</span></span></p>",
    "unique_key": "Q6710823",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264323,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Ans. D. Dexamethasone</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dexamethasone</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is a corticosteroid. Corticosteroids are contraindicated in glaucoma because they can lead to an increase in intraocular pressure (IOP). This rise in IOP can exacerbate glaucoma and potentially cause further damage to the optic nerve.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A. Mannitol:&nbsp;</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mannitol is an osmotic diuretic and is the drug of choice for acute congestive glaucoma when administered intravenously. It decreases IOP by creating an osmotic gradient, which helps to draw fluid out of the eye, thereby reducing congestion.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B. Methazolamide:&nbsp;</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Methazolamide is a carbonic anhydrase inhibitor. It decreases the production of aqueous humor in the eye, which in turn reduces intraocular pressure. Carbonic anhydrase inhibitors are effective in managing glaucoma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C. Clonidine:&nbsp;</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clonidine is an alpha-2 adrenergic agonist. It decreases intraocular pressure by reducing aqueous humor production and increasing uveoscleral outflow. Alpha-2 agonists are commonly used in the treatment of glaucoma.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\">&nbsp;&nbsp;</span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/20/screenshot-2024-07-20-122430.png\" style=\"height:284px; width:1000px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Note </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">- Dexamethasone is contraindicated in glaucoma</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Reference: KDT 8<sup>th</sup>/ 318, 167, 170</span></span></strong></span></span></p>",
    "correct_choice_id": 27607,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6912,
    "choices": [
      {
        "id": 27616,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">5HT4 agonist</span></span></span></p>"
      },
      {
        "id": 27617,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">5HT2b agonist</span></span></span></p>"
      },
      {
        "id": 27618,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">5HT2b antagonist</span></span></span></p>"
      },
      {
        "id": 27619,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">5HT1a partial agonist</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Prucalopride</span></span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\"> is a (AIIMS NOVEMBER 2019)</span></span></span></p>",
    "unique_key": "Q1887151",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264324,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Ans. A. 5HT4 agonist</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">PRUCALOPRIDE</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">It is a selective&nbsp;<strong>5-HT4 receptor agonist</strong>&nbsp;approved recently for the treatment of chronic constipation, when other laxatives fail to provide adequate relief.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">It activates pre-junctional 5-HT4 receptors on intrinsic enteric neurons to enhance release of the excitatory transmitter ACh. It, thereby promotes the propulsive contractions in ileum and more prominently in colon.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Prucalopride is shown to have negligible affinity for cardiac K<sup>+</sup> channels. It is therefore, believed to be free of cardiovascular risk. No Q-T prolongation has been noted during clinical trial.&nbsp;</span></span></span></span></li>\r\n</ul>\r\n\r\n<p><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prucalopride is a selective 5-HT4 receptor agonist used for the treatment of chronic constipation, working by enhancing acetylcholine release to promote intestinal motility without significant cardiovascular risks.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Liberation Serif&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">Reference: KDT 8<sup>th</sup>/724</span></span></strong></span></span></p>",
    "correct_choice_id": 27616,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6961,
    "choices": [
      {
        "id": 27812,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">5-HT antagonist </span></span></span></p>"
      },
      {
        "id": 27813,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">5-HT agonist</span></span></span></p>"
      },
      {
        "id": 27814,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Calcium Channel Blocker action</span></span></span></p>"
      },
      {
        "id": 27815,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nitric oxide mediated vasodilation</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An elderly woman on treatment for migraine presents with chest pain. She has a previous history of ischemic heart disease. Which of the following mechanism of the prescribed drug for migraine might have caused this presentation? (INICET NOV 2020)</span></span></p>",
    "unique_key": "Q1802971",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264325,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. 5-HT agonist</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chest pain in an elderly woman with a history of ischemic heart disease, who is on treatment for migraine, could potentially be linked to the mechanism of action of her migraine medication. Among the options given 5-HT agonists can cause this adverse effect. Triptans and ergotamine are a group of drugs that are used in acute attacks of migraine. They act on 5HT1B/1D receptors as agonist and cause vasoconstriction of the blood vessels. Therefore, they should be avoided in patients with coronary artery disease as they can precipitate myocardial infarction.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>5-HT Antagonist</strong>: Serotonin (5-HT) antagonists like cyproheptadine and methysergide etc are used for prophylaxis of migraine (not in treatment). These drugs are not commonly associated with causing chest pain or exacerbating ischemic heart disease.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Calcium Channel Blocker Action</strong>: While calcium channel blockers (CCBs) are used in migraine prophylaxis, they are generally heart-protective and used in the treatment of angina and hypertension due to their vasodilatory effects. It&#39;s unlikely that CCBs would cause chest pain.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Nitric Oxide Mediated Vasodilation</strong>: Nitric oxide donors (like nitrates) are used in the treatment of angina due to their vasodilatory effects. They are not typically used in migraine treatment, and their vasodilatory action would be more likely to relieve, rather than cause, ischemic chest pain.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">5-HT Agonist</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> includes medications like triptans (e.g., sumatriptan), which are commonly used in migraine treatment. Triptans are 5-HT1B/1D receptor agonists and can cause vasoconstriction of blood vessels. In patients with ischemic heart disease, this vasoconstriction can exacerbate angina (chest pain) or precipitate myocardial infarction, especially if the coronary arteries are already compromised.</span></span></span></p>",
    "correct_choice_id": 27813,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6962,
    "choices": [
      {
        "id": 27816,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pelvic Fracture</span></span></span></p>"
      },
      {
        "id": 27817,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CO2 retention due to opioid use</span></span></span></p>"
      },
      {
        "id": 27818,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cerebral Edema</span></span></span></p>"
      },
      {
        "id": 27819,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pulmonary embolism</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient presented with pelvic fracture and head trauma after a road traffic accident.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">He was given IV morphine for pain relief following which he developed respiratory difficulty. What could be the most likely cause? (INICET NOV 2020)</span></span></p>",
    "unique_key": "Q1206065",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264326,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. CO2 retention due to opioid use</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The development of respiratory difficulty in a patient who received IV morphine for pain relief after sustaining a pelvic fracture and head trauma can be due to several reasons. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Opioids like morphine can depress the respiratory center in the brain, leading to decreased respiratory rate and tidal volume. This can result in CO2 retention and respiratory difficulty, particularly in higher doses or in patients with pre-existing respiratory issues. This is a well-known side effect of opioids and is a common cause of respiratory depression following opioid administration.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Pelvic Fracture</strong>: While a pelvic fracture can be severe and cause significant pain, it is not typically directly associated with the development of respiratory difficulty unless there are associated injuries, such as a pneumothorax or hemorrhage leading to shock.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Cerebral Edema</strong>: Head trauma can lead to cerebral edema, which in turn can affect the brain&#39;s respiratory center. However, the onset of respiratory difficulty immediately following opioid administration suggests that the opioid&#39;s effects are more likely to be the cause, rather than a progression of cerebral edema, which usually develops over a longer period.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Pulmonary Embolism</strong>: A pulmonary embolism (PE) is a possible complication following trauma and immobilization. However, the immediate onset of respiratory difficulty after opioid administration makes PE less likely as the primary cause in this scenario.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Considering the timing and circumstances, the most likely cause of the respiratory difficulty in this patient is <strong>CO2 Retention due to Opioid Use</strong>. Morphine and other opioids can cause respiratory depression, leading to reduced ventilation and CO2 retention. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The CO2 retention can also increase the ICP. Apart from that, miosis is produced by morphine, which makes it difficult for assessment of neurological status in head trauma patients. Therefore, morphine is contraindicated in head injury.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Opioids like morphine can cause respiratory depression by decreasing the respiratory rate and tidal volume, leading to CO2 retention. This effect is particularly concerning in patients with head trauma due to the potential for increased intracranial pressure.</span></span></span></p>",
    "correct_choice_id": 27817,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6963,
    "choices": [
      {
        "id": 27820,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fluoxetine</span></span></span></p>"
      },
      {
        "id": 27821,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Venlafaxine</span></span></span></p>"
      },
      {
        "id": 27822,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mirtazapine</span></span></span></p>"
      },
      {
        "id": 27823,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Imipramine</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following antidepressants causes the least sexual dysfunction? (INICET NOV 2020)</span></span></p>",
    "unique_key": "Q4502766",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264327,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Mirtazapine</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The typical antidepressants (SSRI, SNRI, MAO inhibitors and TCA) are notorious for causing sexual disturbances like erectile dysfunction due to increased levels of serotonin. On the other hand, atypical anti-depressants (like mirtazapine and bupropion etc) have lesser propensity to cause these adverse effects.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Options A. Fluoxetine</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: As a selective serotonin reuptake inhibitor (SSRI), fluoxetine is commonly associated with sexual dysfunction, including decreased libido, difficulty achieving orgasm, and erectile dysfunction.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Options B. Venlafaxine</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is a serotonin-norepinephrine reuptake inhibitor (SNRI). While perhaps slightly less likely to cause sexual side effects than SSRIs, venlafaxine can still lead to sexual </span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">dysfunction in a significant number of patients.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Options D. Imipramine:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> A tricyclic antidepressant (TCA), imipramine can cause sexual dysfunction, often due to its anticholinergic effects. TCAs, in general, are more likely to cause a variety of side effects, including those affecting sexual function.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mirtazapine</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is an atypical antidepressant. Apart from increasing the levels of serotonin and nor-adrenaline (due to blockade of presynaptic alpha 2 receptors), It also acts as an antagonist of serotonin (5-HT2 and 5-HT3) receptors. It has some degree of H1 blocking property also. It is therefore known as NSSA (Nor adrenergic and Specific Serotonergic Antidepressant). Mirtazapine is generally associated with a lower incidence of sexual side effects compared to SSRIs and SNRIs, making it a better option for patients concerned about these issues.</span></span></span></p>",
    "correct_choice_id": 27822,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6965,
    "choices": [
      {
        "id": 27828,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">When used with alcohol, the patients develops nausea, vomiting, flushing, chest discomfort and palpitations </span></span></span></p>"
      },
      {
        "id": 27829,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is an anti-craving drug for alcohol </span></span></span></p>"
      },
      {
        "id": 27830,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It can be initiated even in minimally motivated person </span></span></span></p>"
      },
      {
        "id": 27831,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Its action persists maximum up to 2-3 days after stopping the drug</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following statements is true about disulfiram?&nbsp;</span></span>(INICET Nov 2020)</p>",
    "unique_key": "Q2119624",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264328,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. When used with alcohol, the patients develops nausea, vomiting, flushing, chest discomfort and palpitations</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Disulfiram, when used concurrently with alcohol, causes an accumulation of acetaldehyde in the body due to its inhibition of the enzyme acetaldehyde dehydrogenase. This leads to a range of unpleasant symptoms, including nausea, vomiting, flushing, chest discomfort, and palpitations, which are part of the Disulfiram-alcohol reaction. This reaction is intentional and serves as a deterrent to alcohol consumption. It is given at a dose of 250mg/day, dose may be increased up to 500 mg/day.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Disulfiram is not primarily an anti-craving drug for alcohol. It works by creating an aversive reaction to alcohol rather than reducing the craving for alcohol. Medications like naltrexone or acamprosate are more accurately described as anti-craving drugs.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Disulfiram should be prescribed to highly motivated individuals. It requires a commitment to abstain from alcohol due to the serious nature of the Disulfiram-alcohol reaction. It is not typically recommended for individuals who are minimally motivated or likely to continue consuming alcohol.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The action of Disulfiram can persist beyond 2-3 days after stopping the drug. Its inhibitory effect on acetaldehyde dehydrogenase can last for up to a week or more in some cases, making it possible for the Disulfiram-alcohol reaction to occur even several days after the last dose of Disulfiram.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Disulfiram, when used concurrently with alcohol, causes a severe and unpleasant reaction due to the accumulation of acetaldehyde, including nausea, vomiting, flushing, chest discomfort, and palpitations, serving as a deterrent to alcohol consumption. It should be used in highly motivated individuals committed to abstaining from alcohol.</span></span></span></p>",
    "correct_choice_id": 27828,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6966,
    "choices": [
      {
        "id": 27832,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Calcitonin</span></span></span></p>"
      },
      {
        "id": 27833,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Raloxifene</span></span></span></p>"
      },
      {
        "id": 27834,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bisphosphonates</span></span></span></p>"
      },
      {
        "id": 27835,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Teriparatide</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following drugs promotes bone formation? (</span></span>INICET Nov 2020)</p>",
    "unique_key": "Q8353019",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264329,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. Teriparatide</span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Teriparatide is recombinant PTH analogue that is used in the treatment of osteoporosis. When given in low doses, it stimulates bone formation by mimicking the physiological action of PTH on the osteoblasts.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Options&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A. Calcitonin: Mechanism</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Calcitonin inhibits osteoclast activity, reducing bone resorption. It helps maintain bone density but does not stimulate new bone formation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Options&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B. Raloxifene: Mechanism</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Raloxifene is a selective estrogen receptor modulator (SERM). It inhibits bone resorption by reducing osteoclast activity and is used to prevent bone loss in postmenopausal women, but it does not promote bone formation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Options&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C. Bisphosphonates: Mechanism</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Bisphosphonates, such as alendronate and risedronate, inhibit osteoclast-mediated bone resorption. These drugs help maintain bone density and reduce the risk of fractures, but they do not promote new bone formation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">DRUGS USED IN OSTEOPOROSIS</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/14/screenshot-2023-12-14-151658.jpg\" style=\"height:647px; width:1000px\" /></span></span></span></p>",
    "correct_choice_id": 27835,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6967,
    "choices": [
      {
        "id": 27836,
        "text": "<p><span style=\"font-size:12pt;\">Prednisolone</span></p>"
      },
      {
        "id": 27837,
        "text": "<p><span style=\"font-size:12pt;\">Salbutamol</span></p>"
      },
      {
        "id": 27838,
        "text": "<p><span style=\"font-size:12pt;\">Fexofenadine</span></p>"
      },
      {
        "id": 27839,
        "text": "<p><span style=\"font-size:12pt;\">Amoxicillin</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">A known asthmatic patient with fever and sore throat was prescribed an antibiotic. Two days later he presents with a maculopapular rash. Which of the following drugs might have caused this? (INICET NOV 2020)</span></p>",
    "unique_key": "Q5605965",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264330,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D. Amoxicillin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Out of the options given above, amoxicillin is the only drug which is an antibiotic. It is an amino penicillin. Allergic reactions in the form of skin rashes to Penicillin group of antibiotics are very common, out of which it is the highest with aminopenicillins.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Options A.</strong>&nbsp;<strong>Prednisolone</strong>: This is a corticosteroid used in the treatment of asthma to reduce inflammation. Corticosteroids like prednisolone are not typically associated with causing maculopapular rashes. In fact, they are often used to treat allergic reactions and rashes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Options B.</strong>&nbsp;<strong>Salbutamol</strong>: Also known as albuterol, this is a bronchodilator used to relieve bronchospasm in conditions like asthma. Salbutamol is not commonly associated with skin rashes like a maculopapular rash.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Options C.</strong>&nbsp;<strong>Fexofenadine</strong>: This is an antihistamine used for allergic reactions. It is unlikely to cause a maculopapular rash and is more commonly used to treat such rashes when they are due to allergic reactions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Amoxicillin, an aminopenicillin antibiotic, is commonly associated with allergic reactions, including maculopapular rashes. This is a well-known side effect of penicillin antibiotics. Prednisolone, salbutamol, and fexofenadine are less likely to cause such reactions, and in the case of prednisolone and fexofenadine, they are actually used to treat allergic reactions and rashes.</span></p>",
    "correct_choice_id": 27839,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 6969,
    "choices": [
      {
        "id": 27844,
        "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica\"><span style=\"font-family:Helvetica\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bacterial contamination</span></span></span></span></span></p>"
      },
      {
        "id": 27845,
        "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica\"><span style=\"font-family:Helvetica\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">\ufeff\ufeff\ufeffDoes not provide multiple doses</span></span></span></span></span></p>"
      },
      {
        "id": 27846,
        "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica\"><span style=\"font-family:Helvetica\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">\ufeff\ufeff\ufeffDrug deposition in the oropharynx</span></span></span></span></span></p>"
      },
      {
        "id": 27847,
        "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica\"><span style=\"font-family:Helvetica\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Not portable</span></span></span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-family:Helvetica\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is the most common drawback of the given device? (INICET NOV 2020)</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica\"><span style=\"font-family:Helvetica\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/05/picture3_4FJIap8.jpg\" style=\"height:283px; width:250px\" /></span></span></span></span></span></p>",
    "unique_key": "Q9009968",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264331,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica\"><span style=\"font-family:Helvetica\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C.&nbsp;</span></span></strong></span><span style=\"font-family:Helvetica\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Drug deposition in the oropharynx</span></span></strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica\"><span style=\"font-family:Helvetica\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The given image shows a metered-dose inhaler (MDI). It is a common device used for delivering drugs (like inhaled corticosteroids, bronchodilators etc.) used in the management of bronchial asthma and COPD. </span></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Drug Deposition in the Oropharynx&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is a well-recognized limitation of MDIs. A significant proportion of the medication can deposit in the oropharynx and upper airways instead of reaching the lower respiratory tract where it is needed. This not only reduces the efficiency of the drug delivery to the lungs but can also increase the risk of local side effects, such as oral thrush when using corticosteroid inhalers.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica\"><span style=\"font-family:Helvetica\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Options A.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Bacterial Contamination</strong>: While good hygiene is important in the maintenance of any inhaler device, bacterial contamination is not a commonly cited primary drawback of MDIs. Regular cleaning can typically manage this risk.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Options B.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Does Not Provide Multiple Doses</strong>: This is not accurate. MDIs are designed to provide multiple doses. They contain a pressurized canister that delivers a specific dose of medication in aerosol form with each actuation.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Options D.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Not Portable</strong>: MDIs are actually very portable and convenient, which is one of their advantages. They are compact and easy to carry, making them suitable for use on the go.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The most common drawback of metered-dose inhalers (MDIs) is drug deposition in the oropharynx, which reduces the efficiency of drug delivery to the lungs and can increase the risk of local side effects.</span></span></span></p>",
    "correct_choice_id": 27846,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7050,
    "choices": [
      {
        "id": 28168,
        "text": "<p><span style=\"font-size:12.0pt;\">Adequate safety profile needs to be established</span></p>"
      },
      {
        "id": 28169,
        "text": "<p><span style=\"font-size:12.0pt;\">Cost to benefit has to be considered</span></p>"
      },
      {
        "id": 28170,
        "text": "<p><span style=\"font-size:12.0pt;\">Fixed dose combination of drugs is preferred over single drugs</span></p>"
      },
      {
        "id": 28171,
        "text": "<p><span style=\"font-size:12.0pt;\">Disease prevalence is considered</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following is false about the selection of essential drugs? (INICET MAY 2021)</span></p>",
    "unique_key": "Q8002091",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264332,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Fixed dose combination of drugs is preferred over single drugs</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The WHO has defined Essential Medicines (Drugs) as \u201cthose that satisfy the priority healthcare needs of the population. They are selected with due regard to public health relevance, evidence on efficacy and safety, and comparative cost effectiveness. Essential medicines are intended to be available within the context of functioning health systems at all times and in adequate amounts, in appropriate dosage forms, with assured quality and adequate information, and at a price the individual and the community can afford.\u201d</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This is generally false. While fixed-dose combinations (FDCs) can be beneficial in certain scenarios (like in the treatment of HIV/AIDS or tuberculosis), they are not universally preferred over single-drug formulations. The preference for FDCs or single drugs depends on several factors, including the therapeutic context, the risk of drug-drug interactions, patient adherence, and the potential for resistance development. Mostly, single drugs are preferred due to their flexibility in dosing and the ability to adjust individual components based on patient needs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Adequate safety profile needs to be established</strong>: This is true. When selecting essential drugs, it's crucial that they have a well-established safety profile. Safety is a key consideration to ensure that the benefits of a drug outweigh its risks.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Cost to benefit has to be considered</strong>: This is also true. In the selection of essential drugs, the cost-effectiveness of a drug is an important factor. The aim is to provide the most effective treatment at the lowest possible cost.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Disease prevalence is considered</strong>: This is true. When selecting essential drugs, the prevalence of diseases in a population is an important consideration. Drugs to treat common and life-threatening diseases are typically prioritized.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The selection of essential drugs prioritizes factors like safety, cost-effectiveness, and disease prevalence. Fixed-dose combinations are not universally preferred over single drugs, as the choice depends on specific therapeutic needs and other considerations.</span></p>",
    "correct_choice_id": 28170,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7051,
    "choices": [
      {
        "id": 28172,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chlorothiazide</span></span></span></p>"
      },
      {
        "id": 28173,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chlorthalidone</span></span></span></p>"
      },
      {
        "id": 28174,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Metolazone</span></span></span></p>"
      },
      {
        "id": 28175,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hydrochlorothiazide</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 34-year-old man with hypertension is diagnosed with stage 4 chronic kidney disease, with eGFR of &lt;30. His doctor wants to prescribe a thiazide diuretic. Which of the following can be given? (INICET MAY 2021)</span></span></p>",
    "unique_key": "Q1411292",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264333,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C. Metolazone</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In the context of a patient with stage 4 chronic kidney disease (CKD) and an estimated glomerular filtration rate (eGFR) of less than 30 mL/min, the choice of diuretic is important, as not all diuretics are effective in patients with significantly reduced kidney function. Among the thiazides, metolazone remains effective in presence of severe renal failure whereas traditional thiazides like chlorthalidone, hydrochlorothiazide and chlorthiazide are ineffective.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The reason Metolazone remains effective in patients with advanced chronic kidney disease (CKD), where traditional thiazide diuretics are less effective, lies in their pharmacokinetic properties and the way they interact with kidney function.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Site of Action and Kidney Function:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Thiazide diuretics primarily act on the distal convoluted tubule in the kidney. They inhibit the sodium-chloride symporter, leading to increased excretion of sodium and chloride, and consequently, water.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In advanced CKD, particularly when the eGFR (estimated glomerular filtration rate) falls below 30 mL/min, the kidney function is significantly impaired. Traditional thiazides become less effective because they depend on adequate kidney function to reach their site of action and to exert their diuretic effect.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:96px; text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Pharmacokinetics of Metolazone:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Metolazone is classified as a thiazide-like diuretic. Unlike traditional thiazides, it retains its effectiveness even in patients with reduced kidney function.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This is because metolazone has additional actions on the proximal tubule of the kidney, where it inhibits sodium reabsorption. This proximal action is not as dependent on kidney function as the action in the distal tubule.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Chlorothiazide</strong>: This traditional thiazide diuretic is ineffective in patients with significantly reduced kidney function (eGFR &lt;30 mL/min).</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B</span></strong><span style=\"font-size:12.0pt\">.&nbsp;<strong>Chlorthalidone</strong>: Another traditional thiazide diuretic that is not effective in advanced CKD due to its reliance on adequate kidney function to exert its diuretic effect.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Hydrochlorothiazide</strong>: Like other traditional thiazides, hydrochlorothiazide is ineffective in patients with severe renal impairment.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Metolazone is the preferred thiazide-like diuretic for patients with stage 4 chronic kidney disease and an eGFR of less than 30 mL/min, as it retains its effectiveness even in the presence of significantly reduced kidney function. This is due to its additional action on the proximal tubule, which is less dependent on kidney function.</span></span></span></p>",
    "correct_choice_id": 28174,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7052,
    "choices": [
      {
        "id": 28176,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Increase the dose</span></span></span></p>"
      },
      {
        "id": 28177,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Decrease the dose</span></span></span></p>"
      },
      {
        "id": 28178,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Stop the drug</span></span></span></p>"
      },
      {
        "id": 28179,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Stop retigabine and start on carbamazepine</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient who was diagnosed with epilepsy was put on retigabine thrice a day. Now phenytoin is being added. Which of the following changes should be made to retigabine therapy?</span></span></p>",
    "unique_key": "Q8416392",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264334,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Increase the dose</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In the scenario where phenytoin is added to a patient&#39;s epilepsy treatment regimen that already includes retigabine, and if one of the provided options must be chosen, the most appropriate choice, based on known pharmacological interactions, would be:</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The rationale for this choice is based on the enzyme-inducing properties of phenytoin. Phenytoin is known to induce hepatic enzymes that metabolize many drugs, potentially leading to reduced levels of these drugs. The general principle of enzyme induction suggests that the levels of retigabine could be decreased when phenytoin is added. Therefore, an increase in the dose of retigabine may be necessary to maintain therapeutic drug levels and effective seizure control.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">However, it&#39;s important to emphasize that any dose adjustment should be made cautiously and based on clinical monitoring, including assessing the efficacy of seizure control and watching for any potential side effects. The decision should be individualized and ideally supported by drug level monitoring if available.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Decrease the dose</strong>: Decreasing the dose of retigabine would be counterproductive, as the enzyme-inducing effect of phenytoin would lower the drug levels, requiring an increase rather than a decrease.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Stop the drug</strong>: Stopping retigabine is not advisable without a clear indication of severe side effects or failure to control seizures. Retigabine can be an effective antiepileptic, and its discontinuation should be based on clinical judgment and not just due to the addition of another drug.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D</span></strong><span style=\"font-size:12.0pt\">.&nbsp;<strong>Stop retigabine and start on carbamazepine</strong>: This option suggests switching to another antiepileptic drug. While carbamazepine is another enzyme inducer like phenytoin, switching medications is not necessary unless there are specific reasons to do so, such as intolerability or ineffectiveness of retigabine.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">When phenytoin, an enzyme inducer, is added to a regimen that includes retigabine, the dose of retigabine should be increased to compensate for the increased metabolism and maintain effective seizure control.</span></span></span></p>",
    "correct_choice_id": 28176,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7053,
    "choices": [
      {
        "id": 28180,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Downregulation of CYP2C19</span></span></span></p>"
      },
      {
        "id": 28181,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Downregulation of CYP2D6</span></span></span></p>"
      },
      {
        "id": 28182,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Upregulation of CYP1A1</span></span></span></p>"
      },
      {
        "id": 28183,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Downregulation of CYP2E1</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient of 45 year with history of ischemic stroke was started on clopidogrel, However, she had another attack of stroke after 6 months. Which of the following is likely to be responsible for the failure of clopidogrel in this patient? (INICET MAY 2021)</span></span></p>",
    "unique_key": "Q3096448",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264335,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Downregulation of CYP2C19</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"><br />\r\n<span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Clopidogrel is an antiplatelet drug used to prevent MI and stroke. The failure of clopidogrel in preventing a second stroke in a patient can be influenced by various factors, including genetic variations that affect drug metabolism. </span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Clopidogrel is a prodrug that requires activation by CYP2C19. Genetic polymorphisms or downregulation of CYP2C19 can lead to reduced conversion of clopidogrel to its active form. This results in decreased antiplatelet activity and a higher risk of thrombotic events, such as stroke. Individuals with reduced function alleles of CYP2C19 are known as &quot;poor metabolizers,&quot; and in these patients, clopidogrel may be less effective.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Downregulation of CYP2D6</strong>: While CYP2D6 is important for the metabolism of many drugs, it is not primarily responsible for the activation of clopidogrel. Therefore, downregulation of CYP2D6 would not significantly impact clopidogrel&#39;s effectiveness.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Upregulation of CYP1A1</strong>: CYP1A1 is not involved in the metabolism of clopidogrel. Its upregulation would not affect the activation of clopidogrel or its therapeutic efficacy.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Downregulation of CYP2E1</strong>: CYP2E1 is involved in the metabolism of ethanol and certain other drugs but does not play a significant role in the activation of clopidogrel. Therefore, downregulation of CYP2E1 would not impact clopidogrel&#39;s effectiveness.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The failure of clopidogrel in preventing a second stroke in a patient may be due to the downregulation of CYP2C19. This enzyme is crucial for converting clopidogrel into its active form, and its reduced activity can lead to decreased antiplatelet effects and increased risk of thrombotic events.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/18/screenshot-2024-07-18-111759.png\" style=\"height:500px; width:1000px\" /></span></span></span></p>",
    "correct_choice_id": 28180,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7055,
    "choices": [
      {
        "id": 28188,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Liraglutide</span></span></span></p>"
      },
      {
        "id": 28189,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Metformin</span></span></span></p>"
      },
      {
        "id": 28190,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Sibutramine</span></span></span></p>"
      },
      {
        "id": 28191,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Fenfluramine</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following can be given for long term management of obesity?</span></span></p>",
    "unique_key": "Q5973103",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264336,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Liraglutide</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Liraglutide is an injectable medication originally developed to treat type 2 diabetes but has also been approved for weight management in obesity. It works by mimicking the hormone GLP-1, which regulates appetite and calorie intake. Liraglutide has been shown to be effective for long-term weight management and is considered a viable option for obesity treatment.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><span style=\"font-size:12pt\"><strong>B.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Metformin</strong>: While metformin is primarily used to treat type 2 diabetes, it has been observed to cause modest weight loss in some people. However, it is not primarily indicated for the treatment of obesity and is usually not the first choice solely for weight management.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><span style=\"font-size:12pt\"><strong>C.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Sibutramine</strong>: Sibutramine was previously used as an appetite suppressant for weight loss, but it has been withdrawn from the market in many countries due to cardiovascular safety concerns. Therefore, it is no longer recommended for obesity treatment.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">D. Fenfluramine</span></strong><span style=\"font-size:12.0pt\">: Part of the fen-phen combination, fenfluramine was used for weight loss but was withdrawn from the market due to serious side effects, particularly heart valve issues. Like sibutramine, it is no longer considered safe or appropriate for obesity treatment.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Liraglutide is a viable and approved option for the long-term management of obesity. It works by mimicking the hormone GLP-1 to help regulate appetite and reduce calorie intake. Other Options<strong> </strong>like sibutramine and fenfluramine have been withdrawn from the market due to safety concerns, and metformin, while causing modest weight loss, is not primarily indicated for obesity treatment.</span></span></span></p>",
    "correct_choice_id": 28188,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7058,
    "choices": [
      {
        "id": 28200,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Treatment of migraine</span></span></span></p>"
      },
      {
        "id": 28201,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Treatment of Lennox Gastaut syndrome</span></span></span></p>"
      },
      {
        "id": 28202,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Prophylaxis of ADHD</span></span></span></p>"
      },
      {
        "id": 28203,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Treatment of dementia</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Topiramate is used for? (</span></span>INICET May 2021</p>",
    "unique_key": "Q1421831",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264337,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B. Treatment of Lennox Gastaut syndrome</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Topiramate is an antiepileptic drug that can be used for the treatment of Lennaux-Gestaut Syndrome (characterized by multifocal seizures, having &lt;2.5 Hz spike and wave pattern in EEG). It primarily works by blocking the Na<sup>+</sup> channels, and to some extent it also enhances the GABA receptor currents and limiting the activation of the AMPA-kainate subtype of glutamate receptors.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Topiramate can also be used for:</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">C</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Decreasing the <strong>C</strong>raving of alcohol</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">O</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Obesity</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">M</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Migraine Prophylaxis (not treatment)</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">B</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Bipolar disorder.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">So, among the given options, best answer is Lennox Gastaut syndrome. Do not get confused with migraine as the options specifically mentions the treatment of migraine whereas topiramate is used for prophylaxis of migraine.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Treatment of migraine</strong>: Topiramate is used for the prophylaxis of migraines, not for the acute treatment of migraine attacks.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Prophylaxis of ADHD</strong>: Topiramate is not indicated for the prophylaxis or treatment of ADHD.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Treatment of dementia</strong>: Topiramate is not used for the treatment of dementia.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Topiramate is primarily used for the treatment of Lennox-Gastaut syndrome, a severe form of epilepsy in children. It is also used for the prophylaxis of migraines, reducing alcohol cravings, aiding in weight loss, and as an adjunct therapy for bipolar disorder.</span></span></span></p>",
    "correct_choice_id": 28201,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7081,
    "choices": [
      {
        "id": 28292,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tmax</span></span></span></p>"
      },
      {
        "id": 28293,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Area under the curve</span></span></span></p>"
      },
      {
        "id": 28294,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cmax</span></span></span></p>"
      },
      {
        "id": 28295,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">t1/2</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The extent of drug absorption in plasma concentration vs time graph is represented by:</span></span>(INICET MAY 2022)</p>",
    "unique_key": "Q4893792",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264338,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B. Area under the curve</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Area under the curve (AUC) is a measure of the total drug exposure in the bloodstream over time. It reflects the total amount of drug absorbed and is often used to assess the overall bioavailability of a drug. AUC is crucial for determining the efficacy and safety of a medication.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Tmax (Time to Maximum Concentration):</span></strong><span style=\"font-size:12.0pt\"> Tmax represents the time it takes for a drug to reach its maximum concentration (Cmax) in the bloodstream. It tells about rate of drug absorption. </span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Cmax (Maximum Concentration):</span></strong><span style=\"font-size:12.0pt\"> Cmax represents the highest concentration of a drug in the bloodstream after administration. This parameter is important because it indicates the peak therapeutic effect and helps assess the risk of side effects associated with high drug concentrations.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. t1/2 (Half-Life):</span></strong><span style=\"font-size:12.0pt\"> t1/2 is the time it takes for half of the drug to be eliminated from the bloodstream. It is not directly related to drug absorption but is essential in understanding how long a drug remains in the body and how often it needs to be administered.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The Area Under the Curve (AUC) in a plasma concentration vs. time graph represents the extent of drug absorption, reflecting the total drug exposure over time and the overall bioavailability of the drug.</span></span></span></p>",
    "correct_choice_id": 28293,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7084,
    "choices": [
      {
        "id": 28304,
        "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Drug 1 represents agonist and drug 2 represents inverse agonist\ufeff\ufeff\ufeff</span></span></span></span></span></p>"
      },
      {
        "id": 28305,
        "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Drug 3 represents agonist and drug 4 represents inverse agonist</span></span></span></span></span></p>"
      },
      {
        "id": 28306,
        "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\">\ufeff\ufeff\ufeff<span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Drug 1 represents agonist and drug 4 represents inverse agonist</span></span></span></span></span></p>"
      },
      {
        "id": 28307,
        "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">\ufeff\ufeff\ufeffDrug 2 represents partial agonist and drug 3 represents inverse agonist</span></span></span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span style=\"font-family:Helvetica,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following statement is correct regarding the given graph?</span></span></span>(INICET May 2022)</p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/06/pharmc-1-4.jpg\" style=\"height:277px; width:300px\" /></span></span></span></span></p>",
    "unique_key": "Q4238162",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264339,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C.&nbsp;</span></span></strong><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Drug 1 represents agonist and drug 4 represents inverse agonist</span></span></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Drug 1 = Full agonist, showing the maximal effect, having an intrinsic efficacy of +1</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">E.g., Salbutamol is a &beta;2 receptor agonist</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Drug 2 = Partial agonist, produces submaximal effect and has an intrinsic efficacy in the range of 0 to +1. E.g., Buprenorphine at the opioid receptors.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Drug 3 = Antagonist, having no effect of its own at the receptor, that is an intrinsic efficacy of 0.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">E.g., Naltrexone and Naloxone at the opioid receptors.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Drug 4 = Inverse agonist, produces opposite effect and has a negative intrinsic efficacy.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">E.g., Beta-</span><span style=\"font-size:12.0pt\">Carboline is an inverse agonist at benzodiazepine site of GABA-A receptor.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Drug 1</span></strong><span style=\"font-size:12.0pt\">: Shows the highest level of response, indicating it is a full agonist.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Drug 2</span></strong><span style=\"font-size:12.0pt\">: Shows a submaximal response, indicating it is a partial agonist.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Drug 3</span></strong><span style=\"font-size:12.0pt\">: Shows no change in response, indicating it is an antagonist.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Drug 4</span></strong><span style=\"font-size:12.0pt\">: Shows a negative response, indicating it is an inverse agonist.</span></span></span></p>",
    "correct_choice_id": 28306,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7085,
    "choices": [
      {
        "id": 28308,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Nivolumab</span></span></span></p>"
      },
      {
        "id": 28309,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pembrolizumab</span></span></span></p>"
      },
      {
        "id": 28310,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Trastuzumab</span></span></span></p>"
      },
      {
        "id": 28311,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ipilimumab</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which among the following drugs is the new FDA approved immune check point inhibitor for carcinoma endometrium?</span></span></span>(INICET MAY 2022)</p>",
    "unique_key": "Q1064135",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264340,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B. Pembrolizumab</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The new FDA-approved immune checkpoint inhibitor for carcinoma endometrium is Pembrolizumab.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pembrolizumab is a monoclonal antibody against PD-1 receptor (Programmed Death Receptor) that can be used for many cancers including endometrial carcinoma. Some of the other cancers where it is useful are:</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Metastatic urothelial cancer</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Refractory melanoma</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hodgkin&rsquo;s Lymphoma</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Merkel cell cancer</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chemotherapy Refractory Head and Neck Cancer</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>Nivolumab:</strong> is an immune checkpoint inhibitor that acts by inhibiting programmed death receptor - 1 (PD-1) and is used for the treatment of advanced melanoma and relapsed/refractory classical Hodgkin lymphoma.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>Trastuzumab: </strong>is a monoclonal antibody that inhibits the HER2 receptor. It is used in the treatment of HER2-positive breast cancer.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>Ipilimumab:</strong> is a monoclonal antibody that binds to cytotoxic T lymphocyte-associated Protein 4 (CTLA-4) and is approved for the treatment of late-stage melanoma.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pembrolizumab is the new FDA-approved immune checkpoint inhibitor for carcinoma endometrium. It works by blocking the PD-1 receptor, enhancing the immune system&#39;s ability to attack cancer cells. It is also used for treating several other cancers, including metastatic urothelial cancer, refractory melanoma, Hodgkin&rsquo;s lymphoma, Merkel cell cancer, and chemotherapy-refractory head and neck cancer.</span></span></span></p>",
    "correct_choice_id": 28309,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7086,
    "choices": [
      {
        "id": 28312,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Nivolumab</span></span></span></p>"
      },
      {
        "id": 28313,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pembrolizumab</span></span></span></p>"
      },
      {
        "id": 28314,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Atezolimumab</span></span></span></p>"
      },
      {
        "id": 28315,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cetuximab</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is not an immune checkpoint inhibitor?&nbsp;</span></span>(INICET MAY 2022)</p>",
    "unique_key": "Q1571094",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264341,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D. Cetuximab&nbsp; </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cetuximab is a monoclonal antibody against EGFR (Epidermal Growth Factor Receptor). It is used in the treatment of Colorectal and Head and Neck Cancers. It is not an immune check point inhibitor.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Nivolumab is an immune checkpoint inhibitor. It acts by inhibiting programmed death receptor - 1 (PD-1) and are used for the treatment of advanced melanoma and classical Hodgkin lymphoma.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Pembrolizumab is an immune checkpoint inhibitor. It acts by inhibiting programmed death receptor</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">- 1 (PD-1) and are used for the treatment of advanced melanoma.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Atezolimumab is an immune checkpoint inhibitor. It acts by inhibiting programmed death-ligand - 1 (PDL-1) and is used for the treatment of urothelial, breast and non-small cell lung cancers.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Important immune check point inhibitors include:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">N</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">ew: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>N</strong>ivolumab</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">D</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">rugs: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>D</strong>urvalumab</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">ct: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>A</strong>velumab</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">At</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>At</strong>ezolizumab</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">I</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">mmune: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>I</strong>pilimumab</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">C</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">heck: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>C</strong>emiplimab</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">P</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">oint: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>P</strong>embrolizumab</span></span></span></p>",
    "correct_choice_id": 28315,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7089,
    "choices": [
      {
        "id": 28324,
        "text": "<p><span style=\"font-size:12.0pt;\">Aspirin</span></p>"
      },
      {
        "id": 28325,
        "text": "<p><span style=\"font-size:12.0pt;\">Paracetamol</span></p>"
      },
      {
        "id": 28326,
        "text": "<p><span style=\"font-size:12.0pt;\">Diclofenac</span></p>"
      },
      {
        "id": 28327,
        "text": "<p><span style=\"font-size:12.0pt;\">Ketorolac</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">NAPQI is the metabolite of which of the following drug toxicity? (</span><span style=\"background-color:rgb(255,255,255);color:rgb(111,126,149);font-size:14px;\">INICET May 2022)</span></p>",
    "unique_key": "Q2457550",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264342,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Paracetamol</strong></span></p><p><br><span style=\"font-size:12.0pt;\">N-acetyl-p-benzoquinone imine (NAPQI) is a metabolite of paracetamol drug toxicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">NAPQI is highly reactive and has high affinity for sulfydryl groups. It causes enzymatic dysfunction in the liver. Normally, minor amounts of NAPQI produced in our body are rapidly eliminated by conjugation with reduced glutathione (GSH) that acts as a source of sulfhydryl group and then excreted into the urine.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Therefore, paracetamol toxicity is treated with N-acetyl cysteine (NAC), which provides the sulfhydryl group. NAC thereby helps in the excretion of NAPQI from the body.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The maximum recommended dose of acetaminophen is 4g/day.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Aspirin</strong>: Aspirin toxicity is not associated with NAPQI. Aspirin overdose primarily causes metabolic acidosis, respiratory alkalosis, and can lead to salicylate poisoning.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Diclofenac</strong>: Diclofenac toxicity does not involve NAPQI. Diclofenac is an NSAID that can cause gastrointestinal and renal toxicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Ketorolac</strong>: Ketorolac toxicity is not associated with NAPQI. Like other NSAIDs, ketorolac can cause gastrointestinal bleeding and renal toxicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">NAPQI is a toxic metabolite produced during the metabolism of paracetamol. In cases of paracetamol overdose, NAPQI accumulates and causes liver damage. The antidote for paracetamol toxicity is N-acetylcysteine (NAC), which helps detoxify NAPQI by replenishing glutathione and providing sulfhydryl groups.</span></p>",
    "correct_choice_id": 28325,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7091,
    "choices": [
      {
        "id": 28332,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hydralazine - heart failure</span></span></span></p>"
      },
      {
        "id": 28333,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Atenolol - hemolytic anemia</span></span></span></p>"
      },
      {
        "id": 28334,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Aliskiren - hypokalemia</span></span></span></p>"
      },
      {
        "id": 28335,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Verapamil &ndash; constipation</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify the correct match, regarding the drug and its adverse effect?</span></span>(INICET MAY 2022)</p>",
    "unique_key": "Q8115689",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264343,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. Verapamil &ndash; constipation</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">The correct match regarding the drug and its adverse effect (read carefully, they have not asked the indication) is verapamil causes constipation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Verapamil is a Non DHP calcium channel blocker. It can cause constipation as its side effect.</span></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">. Hydralazine is a vasodilator which can cause drug-induced lupus. It does not cause heart failure as an adverse effect, rather It is used in treatment of heart failure.</span></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">. Atenolol is a cardio selective beta blocker. Bradycardia can be seen as a side effect, not hemolytic anemia. Hemolytic anemia is a side effect of methyl dopa.</span></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">. Aliskiren is a direct renin inhibitor. The side effect of aliskiren is hyperkalemia and not hypokalemia.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Verapamil, a non-dihydropyridine calcium channel blocker, is associated with constipation as a common adverse effect. Other drugs and their incorrect matches in this context include hydralazine (which can cause drug-induced lupus), atenolol (which does not cause hemolytic anemia), and aliskiren (which can cause hyperkalemia, not hypokalemia).</span></span></span></p>",
    "correct_choice_id": 28335,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7092,
    "choices": [
      {
        "id": 28336,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1 month</span></span></span></p>"
      },
      {
        "id": 28337,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">3 months</span></span></span></p>"
      },
      {
        "id": 28338,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">No need to stop</span></span></span></p>"
      },
      {
        "id": 28339,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Can be stopped and conceived soon after stopping</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A lady who had undergone mastectomy for breast cancer is being treated with tamoxifen. How long should it be stopped for before she can conceive?</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;</span></span>&nbsp;(INICET MAY 2022)</p>",
    "unique_key": "Q5758754",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264344,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B. 3 months</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tamoxifen is a Selective Estrogen Receptor Modulator (SERM), which is used in Premenopausal women having ER +ve breast cancer, because of its anti-estrogenic action in the breast. It prevents the chance of recurrence of breast cancer after surgery. </span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The half-life of tamoxifen is approximately 5 to 7 days, but its active metabolites can persist in the body for several weeks. To minimize any risk to a potential pregnancy, it is recommended to stop tamoxifen at least 3 months before trying to conceive.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tamoxifen has teratogenic effects, such as craniofacial abnormalities and reproductive tract abnormalities. It is also stopped during lactation as it is secreted in breast milk. </span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Tamoxifen should be stopped for at least 3 months before attempting to conceive due to its long half-life and potential teratogenic effects. This ensures that the drug and its active metabolites are sufficiently cleared from the body, reducing the risk of harm to the fetus.</span></span></span></p>",
    "correct_choice_id": 28337,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 24709,
    "choices": [
      {
        "id": 98797,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lapatinib</span></span></span></p>"
      },
      {
        "id": 98798,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Sorafenib</span></span></span></p>"
      },
      {
        "id": 98799,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Vismodegib</span></span></span></p>"
      },
      {
        "id": 98800,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Erlotinib</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 60-year-old female is diagnosed with breast cancer. Her tumor is found to be HER2-positive but estrogen receptor (ER) and progesterone receptor (PR) negative. The tumor was resistant to trastuzumab.<strong> </strong>Which of the following drugs is most likely to be effective in the treatment of this patient&#39;s breast cancer?</span></span>(INICET MAY 2023)</p>",
    "unique_key": "Q3073463",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264345,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A. Lapatinib</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lapatinib is a tyrosine kinase inhibitor that can be used for the treatment of HER2-positive but trastuzumab-resistant breast cancer. Trastuzumab is a monoclonal antibody that is commonly used for the treatment of HER2-positive breast cancer, but some patients may develop resistance to this drug over time. Lapatinib works by targeting the HER2 receptor, which is overexpressed in HER2-positive breast cancer, and can be effective in treating breast cancer that has become resistant to trastuzumab. </span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B.</span></strong><span style=\"font-size:12.0pt\"> Sorafenib is a kinase inhibitor that is primarily used for the treatment of advanced liver cancer and kidney cancer. It works by blocking the activity of several proteins that promote the growth and spread of cancer cells.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C.</span></strong><span style=\"font-size:12.0pt\"> Vismodegib is a hedgehog pathway inhibitor that is used for the treatment of basal cell carcinoma, a type of skin cancer. It works by blocking the hedgehog signalling pathway, which is involved in the development and growth of cancer cells.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D.</span></strong><span style=\"font-size:12.0pt\"> Erlotinib is a tyrosine kinase inhibitor that is used for the treatment of non-small cell lung cancer, pancreatic cancer, and other types of cancer. It works by blocking the activity of the epidermal growth factor receptor (EGFR), which is involved in the growth and spread of cancer cells.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lapatinib is an effective treatment for HER2-positive breast cancer, especially in cases where the cancer has become resistant to trastuzumab. It works by targeting the HER2 receptor and can help manage this specific type of breast cancer.</span></span></span></p>",
    "correct_choice_id": 98797,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 24710,
    "choices": [
      {
        "id": 98801,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Matzke scale</span></span></span></p>"
      },
      {
        "id": 98802,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Salazar scale</span></span></span></p>"
      },
      {
        "id": 98803,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Rummack-mathew</span> <span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">scale</span></span></span></p>"
      },
      {
        "id": 98804,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Krutzko scale</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Vancomycin nomogram is known as&nbsp;</span></span></span>(INICET MAY 2023)</p>",
    "unique_key": "Q3706398",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264346,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A. Matzke scale</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The Vancomycin nomogram is also known as the Matzke nomogram or the Matzke scale. It is a tool used to help predict the appropriate dose of vancomycin, an antibiotic, based on the patient&#39;s creatinine clearance and trough serum concentration. The nomogram is a graphical representation that allows healthcare providers to quickly and easily determine the optimal dose of vancomycin for a given patient, taking into account factors such as kidney function and the patient&#39;s weight. </span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Salazar scale</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This nomogram is not related to vancomycin dosing. It is used to predict overall survival of patients with cancer.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Rummack-Matthew scale</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is used to assess potential hepatotoxicity after acetaminophen intake based on serum acetaminophen concentration.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Krutzko scale</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: There is no widely recognized medical scale or nomogram known as the Krutzko scale.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The Vancomycin nomogram, also known as the Matzke scale, is a crucial tool for determining the appropriate dosing of vancomycin based on creatinine clearance and trough serum concentration, ensuring both efficacy and safety in patient treatment.</span></span></span></p>",
    "correct_choice_id": 98801,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 24711,
    "choices": [
      {
        "id": 98805,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The ratio of the median lethal dose to the median effective dose in an individual. </span></span></span></p>"
      },
      {
        "id": 98806,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The range of doses at which a drug is effective without causing significant adverse effects. </span></span></span></p>"
      },
      {
        "id": 98807,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The ratio of the median lethal dose to the median effective dose in a population. </span></span></span></p>"
      },
      {
        "id": 98808,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The dosage at which a drug is both safe and effective in the majority of patients.</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Clinical </span><span style=\"font-size:12.0pt\">Therapeutic Index of a drug is best described as:&nbsp;</span></span></span>(INICET MAY 2023)</p>",
    "unique_key": "Q3673197",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264347,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C. The ratio of the median lethal dose to the median effective dose in a population.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The Clinical Therapeutic Index of a drug is best described as the ratio of the median lethal dose (LD50) to the median effective dose (ED50). Both LD50 and ED50 are calculated by checking different doses in a population. </span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It represents the margin of safety of a drug. A higher Clinical Therapeutic Index indicates that a drug has a greater margin of safety, and can be given at higher doses without causing significant adverse effects. </span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The Clinical Therapeutic Index is an important consideration in the development and use of new medications, and helps healthcare providers determine the appropriate dose for individual patients.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:24px; text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. The ratio of the median lethal dose to the median effective dose in an individual</span></strong><span style=\"font-size:12.0pt\">: This description is incorrect because the therapeutic index is determined based on population data, not individual data.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. The range of doses at which a drug is effective without causing significant adverse effects</span></strong><span style=\"font-size:12.0pt\">: This describes the therapeutic window or therapeutic range, not the therapeutic index.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. The dosage at which a drug is both safe and effective in the majority of patients</span></strong><span style=\"font-size:12.0pt\">: This is a general description of an effective and safe dosage regimen but does not specifically describe the therapeutic index.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The Clinical Therapeutic Index of a drug is the ratio of the median lethal dose (LD50) to the median effective dose (ED50) in a population, representing the drug&#39;s margin of safety. A higher Therapeutic Index indicates a greater margin of safety.</span></span></span></p>",
    "correct_choice_id": 98807,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 24712,
    "choices": [
      {
        "id": 98809,
        "text": "<p><span style=\"font-size:12.0pt;\">A-2, B-3, C-4, D-1</span></p>"
      },
      {
        "id": 98810,
        "text": "<p><span style=\"font-size:12.0pt;\">A-3, B-4, C-1, D-2</span></p>"
      },
      {
        "id": 98811,
        "text": "<p><span style=\"font-size:12.0pt;\">A-4, B-2, C-3, D-1</span></p>"
      },
      {
        "id": 98812,
        "text": "<p><span style=\"font-size:12.0pt;\">A-1, B-2, C-3, D-4</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Match the following drugs with the receptors they act upon:&nbsp;</span>(INICET MAY 2023)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/02/screenshot-2023-12-02-102705.png\" alt=\"\" width=\"700\" height=\"375\"></span></p>",
    "unique_key": "Q1989528",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264348,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. A-3, B-4, C-1, D-2</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/11/whatsapp-image-2023-07-04-at-125667.jpg\" alt=\"\" width=\"900\" height=\"316\"></p><p>&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>A-3. Mirabegron&nbsp;</strong>acts on <strong>\u03b23</strong> receptors. Mirabegron is a \u03b23 adrenergic receptor agonist used for the treatment of bladder incontinence by relaxing the detrusor muscle during the storage phase of the urinary bladder fill-void cycle.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>B-4. Indacaterol&nbsp;</strong>acts on <strong>\u03b22</strong> receptors. Indacaterol is a long-acting \u03b22 adrenergic agonist used in the treatment of chronic obstructive pulmonary disease (COPD).</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>C-1. Betaxolol&nbsp;</strong>acts on <strong>\u03b21</strong> receptors. Betaxolol is a \u03b21 selective blocker used in the treatment of hypertension and glaucoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>D-2. Isoproterenol</strong> acts on <strong>\u03b21 \u03b22</strong> receptors. Isoproterenol is a non-selective \u03b2 adrenergic agonist with no \u03b1 action, used in the treatment of bradycardia and heart block.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/11/whatsapp-image-2023-07-04-at-125668.jpg\" alt=\"\" width=\"900\" height=\"243\"></p>",
    "correct_choice_id": 98810,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 24713,
    "choices": [
      {
        "id": 98813,
        "text": "<p><span style=\"font-size:12.0pt;\">Inhibition of angiogenesis</span></p>"
      },
      {
        "id": 98814,
        "text": "<p><span style=\"font-size:12.0pt;\">Increase in IL-2, IL-4 and IL-5</span></p>"
      },
      {
        "id": 98815,
        "text": "<p><span style=\"font-size:12.0pt;\">Generation of oxygen free radicals</span></p>"
      },
      {
        "id": 98816,
        "text": "<p><span style=\"font-size:12.0pt;\">Binding to cereblon</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Mechanism of thalidomide teratogenicity include all except</span></p>",
    "unique_key": "Q1834330",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264349,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Increase in IL-2, IL-4 and IL-5</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Thalidomide actually suppresses the production of certain cytokines, including IL-2, IL-4, and IL-5. The suppression of these interleukins is part of its immunomodulatory effects, not a mechanism of teratogenicity. Thalidomide suppresses the production of interleukins which is an important mechanism in treatment of multiple myeloma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The exact mechanism of thalidomide's teratogenicity is not completely understood, but several mechanisms have been proposed:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Inhibition of angiogenesis</strong>: Thalidomide has been found to inhibit angiogenesis, which is the formation of new blood vessels. This inhibition can disrupt the development of the fetus, leading to birth defects. This mechanism is widely accepted as a significant contributor to the teratogenic effects of thalidomide.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Generation of oxygen free radicals</strong>: Thalidomide may cause oxidative stress by generating oxygen free radicals, which can damage developing cells. This oxidative stress can contribute to teratogenic effects.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Binding to cereblon</strong>: Recent studies have shown that thalidomide binds to a protein called cereblon, which is involved in limb outgrowth and ear development. When thalidomide binds to cereblon, it disrupts the normal function of this protein, leading to the birth defects associated with thalidomide use.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Other mechanism includes -</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Interference with cellular signalling:</strong> Thalidomide may interfere with various cellular signalling pathways, such as those involving fibroblast growth factors, which are important for embryonic development.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Thalidomide's teratogenicity is primarily associated with mechanisms such as the inhibition of angiogenesis, generation of oxygen free radicals, and binding to the cereblon protein. It does not cause an increase in IL-2, IL-4, and IL-5; in fact, it suppresses these interleukins.</span></p>",
    "correct_choice_id": 98814,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 24714,
    "choices": [
      {
        "id": 98817,
        "text": "<p><span style=\"font-size:12.0pt;\">T790M mutation</span></p>"
      },
      {
        "id": 98818,
        "text": "<p><span style=\"font-size:12.0pt;\">L858R mutation</span></p>"
      },
      {
        "id": 98819,
        "text": "<p><span style=\"font-size:12.0pt;\">T890M mutation</span></p>"
      },
      {
        "id": 98820,
        "text": "<p><span style=\"font-size:12.0pt;\">M790T mutation</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A patient is diagnosed with non-small cell lung carcinoma (NSCLC). Molecular testing reveals a specific mutation in the EGFR gene. The oncologist is considering using targeted therapy. For which of the following EGFR mutations is Osimertinib most appropriately used to treat non-small cell lung carcinoma?&nbsp;</span>(INICET MAY 2023)</p>",
    "unique_key": "Q7296059",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264350,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. T790M mutation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Osimertinib</strong> is a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) that is particularly effective in treating non-small cell lung carcinoma (NSCLC) patients who have developed resistance to first-generation EGFR inhibitors (such as gefitinib or erlotinib) due to the T790M mutation in the EGFR gene. This mutation is a common mechanism of acquired resistance, and Osimertinib is specifically designed to target it.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;<strong>L858R mutation</strong> is another common EGFR mutation seen in NSCLC. Although Osimertinib can also be used for L858R mutations, it is not specifically indicated as the primary treatment for this mutation. First-generation EGFR inhibitors like gefitinib or erlotinib are often used for L858R mutations.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C</strong>.&nbsp;<strong>T890M mutation</strong> and <strong>Option D</strong>. <strong>M790T mutation</strong> are not recognized mutations associated with EGFR in the context of NSCLC, and there is no evidence to suggest that Osimertinib is used for these mutations.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/02/screenshot-2023-12-02-110037.png\" alt=\"\" width=\"1000\" height=\"457\"></span></p>",
    "correct_choice_id": 98817,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 44779,
    "choices": [
      {
        "id": 178763,
        "text": "<p><span style=\"font-size:12pt;\">Acetylcholine</span></p>"
      },
      {
        "id": 178764,
        "text": "<p><span style=\"font-size:12pt;\">Dopamine</span></p>"
      },
      {
        "id": 178765,
        "text": "<p><span style=\"font-size:12pt;\">Epinephrine</span></p>"
      },
      {
        "id": 178766,
        "text": "<p><span style=\"font-size:12pt;\">Nor Epinephrine</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">Which of the following neurotransmitters is released from SA node in response to increase in blood pressure?</span></p>",
    "unique_key": "Q6824575",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264351,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Acetylcholine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Acetylcholine is the primary neurotransmitter released by the parasympathetic nervous system. When blood pressure increases, baroreceptors in the carotid sinus and aortic arch detect this change and stimulate the parasympathetic nervous system. This leads to the release of acetylcholine from the vagus nerve at the SA node, resulting in a decrease in heart rate (bradycardia) and a reduction in cardiac output, which helps to lower blood pressure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option&nbsp;B.</strong>&nbsp;<strong>Dopamine</strong>: Dopamine is a neurotransmitter involved in several central nervous system functions, including movement and reward. It is not directly involved in the regulation of heart rate or blood pressure in the context of the SA node.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>C.</strong>&nbsp;<strong>Epinephrine</strong>: Epinephrine (adrenaline) is released by the adrenal medulla and acts on both alpha and beta adrenergic receptors. It generally increases heart rate and blood pressure. It is not released from the SA node in response to increased blood pressure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>D.</strong>&nbsp;<strong>Norepinephrine</strong>: Norepinephrine is a neurotransmitter released by the sympathetic nervous system. It acts on alpha and beta adrenergic receptors to increase heart rate and blood pressure. However, in response to increased blood pressure, the sympathetic activity is typically reduced, and norepinephrine release is decreased.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In summary, the correct neurotransmitter released from the SA node in response to an increase in blood pressure is acetylcholine, as it is part of the parasympathetic response to decrease heart rate and lower blood pressure.</span></p>",
    "correct_choice_id": 178763,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 44782,
    "choices": [
      {
        "id": 178775,
        "text": "<p><span style=\"font-size:12pt;\">Dapsone</span></p>"
      },
      {
        "id": 178776,
        "text": "<p><span style=\"font-size:12pt;\">Ofloxacin</span></p>"
      },
      {
        "id": 178777,
        "text": "<p><span style=\"font-size:12pt;\">Rifampicin</span></p>"
      },
      {
        "id": 178778,
        "text": "<p><span style=\"font-size:12pt;\">Clofazimine</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">Which of the following drugs used in treatment of leprosy can result in hyperpigmentation?</span></p>",
    "unique_key": "Q3485053",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264352,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Clofazimine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Clofazimine is known to cause hyperpigmentation of the skin. This drug is used in leprosy treatment for its anti-inflammatory properties and its ability to kill Mycobacterium leprae. Clofazimine can lead to a characteristic reddish-brown to black discoloration of the skin, which can be quite distressing to patients but is usually harmless.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>A.</strong>&nbsp;<strong>Dapsone</strong>: Dapsone is an antibiotic commonly used in the treatment of leprosy. While it has various side effects, hyperpigmentation is not typically associated with dapsone. Common side effects include hemolysis (especially in individuals with G6PD deficiency) and peripheral neuropathy.</span></p><p style=\"margin-left:48px;\">&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>B.</strong>&nbsp;<strong>Ofloxacin</strong>: Ofloxacin is a fluoroquinolone antibiotic that can be used as part of alternative regimens for leprosy. Hyperpigmentation is not a known side effect of ofloxacin. Its common side effects include gastrointestinal disturbances and tendinitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>C.</strong>&nbsp;<strong>Rifampicin</strong>: Rifampicin is another cornerstone drug in the treatment of leprosy. It can cause orange-red discoloration of body fluids (such as urine, sweat, and tears), but it does not typically cause hyperpigmentation of the skin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In this case, the patient's hyperpigmentation is most likely due to clofazimine. This side effect is well-documented and is a result of the drug accumulating in the skin.</span></p>",
    "correct_choice_id": 178778,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 44783,
    "choices": [
      {
        "id": 178779,
        "text": "<p><span style=\"font-size:16px;\">Osteonecrosis of jaw bone</span></p>"
      },
      {
        "id": 178780,
        "text": "<p><span style=\"font-size:16px;\">Osteosarcoma</span></p>"
      },
      {
        "id": 178781,
        "text": "<p><span style=\"font-size:16px;\">Subtrochanteric fracture</span></p>"
      },
      {
        "id": 178782,
        "text": "<p><span style=\"font-size:16px;\">Loss of bone mass</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">Which of the following is an adverse effect with the long-term use of intermittent teriparatide for treatment of osteoporosis?</span></p>",
    "unique_key": "Q9508508",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264353,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B) Osteosarcoma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Osteosarcoma is a rare but serious potential adverse effect associated with the long-term use of teriparatide. This risk was identified in animal studies where high doses of teriparatide caused osteosarcoma in rats. Although this effect has not been conclusively demonstrated in humans, the potential risk has led to caution in prescribing teriparatide for long durations, usually limited to a maximum of 2 years of use.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option</strong>&nbsp;<strong>A.</strong>&nbsp;<strong>Osteonecrosis of the jaw bone</strong>:&nbsp;Osteonecrosis of the jaw is more commonly associated with bisphosphonates and denosumab, not with teriparatide. Teriparatide, being a parathyroid hormone analog, does not typically cause this condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option</strong>&nbsp;<strong>C.</strong>&nbsp;<strong>Subtrochanteric fracture</strong>:&nbsp;Subtrochanteric fractures are more commonly associated with long-term use of bisphosphonates rather than teriparatide. Teriparatide, by stimulating new bone formation, is less likely to cause these types of fractures.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option</strong>&nbsp;<strong>D.</strong>&nbsp;<strong>Loss of bone mass</strong>:&nbsp;Teriparatide is used to increase bone mass and strength by stimulating bone formation. Loss of bone mass is not a recognized adverse effect of teriparatide; rather, the medication is prescribed to counteract this condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">In summary, the most significant potential adverse effect associated with the long-term use of teriparatide is the development of osteosarcoma, albeit this risk is based primarily on animal studies. Therefore, clinicians are advised to limit the duration of teriparatide therapy and monitor patients closely.</span></p>",
    "correct_choice_id": 178780,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 44786,
    "choices": [
      {
        "id": 178791,
        "text": "<p><span style=\"font-size:12pt;\">Dapagliflozin</span></p>"
      },
      {
        "id": 178792,
        "text": "<p><span style=\"font-size:12pt;\">Pioglitazone</span></p>"
      },
      {
        "id": 178793,
        "text": "<p><span style=\"font-size:12pt;\">Sitagliptin</span></p>"
      },
      {
        "id": 178794,
        "text": "<p><span style=\"font-size:12pt;\">Metformin</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following anti-diabetic drug is associated with increased risk of urinary tract infections? (</span>INICET May 2024)</p>",
    "unique_key": "Q4462466",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264354,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Dapagliflozin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Dapagliflozin is a sodium-glucose cotransporter-2 (SGLT2) inhibitor. SGLT2 inhibitors work by promoting the excretion of glucose through the urine. This increased urinary glucose can create an environment that promotes the growth of bacteria, thereby increasing the risk of urinary tract infections. This class of drugs is well known for its association with UTIs and genital infections.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>B.</strong>&nbsp;<strong>Pioglitazone</strong>:&nbsp;Pioglitazone is a thiazolidinedione that improves insulin sensitivity. It is not associated with an increased risk of urinary tract infections. Common side effects include weight gain, edema, and an increased risk of heart failure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>C.</strong>&nbsp;<strong>Sitagliptin</strong>:&nbsp;Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor. It works by increasing incretin levels, which in turn increase insulin secretion and decrease glucagon secretion. Sitagliptin is not commonly associated with an increased risk of urinary tract infections.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>D.</strong>&nbsp;<strong>Metformin</strong>:&nbsp;Metformin is a biguanide that decreases hepatic glucose production and improves insulin sensitivity. It is not associated with an increased risk of urinary tract infections. Common side effects of metformin include gastrointestinal disturbances such as diarrhea and abdominal discomfort.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In summary, dapagliflozin, an SGLT2 inhibitor, is associated with an increased risk of urinary tract infections due to its mechanism of increasing glucose excretion in the urine. This patient\u2019s recurrent UTIs could be related to her use of dapagliflozin.</span></p>",
    "correct_choice_id": 178791,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 44790,
    "choices": [
      {
        "id": 178807,
        "text": "<p><span style=\"font-size:12pt;\">SGLT2 inhibitors</span></p>"
      },
      {
        "id": 178808,
        "text": "<p><span style=\"font-size:12pt;\">Finerenone</span></p>"
      },
      {
        "id": 178809,
        "text": "<p><span style=\"font-size:12pt;\">Hydrochlorthiazide</span></p>"
      },
      {
        "id": 178810,
        "text": "<p><span style=\"font-size:12.0pt;\">Angiotensin receptor blockers</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A 55-year-old patient presents to the clinic with a history of hyperglycemia and has had positive urine glucose tests on two separate occasions in the last six months. The patient has been diagnosed with type 2 diabetes mellitus. The physician is considering various medications to manage the patient's condition and prevent potential complications, including renal involvement. Which of the following drugs will not delay renal involvement? (</span>INICET May 2024)</p>",
    "unique_key": "Q1724241",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264355,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Hydrochlorothiazide</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Hydrochlorothiazide is a thiazide diuretic used to treat hypertension.&nbsp;</span></li><li><span style=\"font-size:12pt;\">While effective at lowering blood pressure, it does not have specific renal protective effects and may not delay the progression of renal disease in diabetic patients.&nbsp;</span></li><li><span style=\"font-size:12pt;\">In fact, in some cases, thiazide diuretics can increase the risk of developing hyperglycemia.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>A.</strong>&nbsp;<strong>SGLT2 inhibitors</strong>: SGLT2 inhibitors (e.g., canagliflozin, dapagliflozin) are a class of medications used to lower blood sugar in patients with type 2 diabetes. They work by promoting glucose excretion through the urine. Importantly, SGLT2 inhibitors have been shown to provide renal protection and delay the progression of diabetic kidney disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>B.</strong>&nbsp;<strong>Finerenone: </strong>It is a non-steroidal mineralocorticoid receptor antagonist that reduces inflammation and fibrosis in the kidneys. Clinical trials have demonstrated that finerenone can reduce the risk of kidney disease progression in patients with chronic kidney disease and type 2 diabetes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>D.</strong>&nbsp;<strong>Angiotensin receptor blockers (ARBs)</strong>: ARBs (e.g., losartan, valsartan) are another class of medications used to manage hypertension and heart failure. Like ACE inhibitors, ARBs have been shown to provide renal protection and delay the progression of diabetic nephropathy by reducing proteinuria and lowering intraglomerular pressure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In summary, while SGLT2 inhibitors, ACE inhibitors, and ARBs have renal protective properties and can help delay renal involvement in diabetic patients, hydrochlorothiazide does not have these specific protective effects and is the correct answer in this context.</span></p>",
    "correct_choice_id": 178809,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 44800,
    "choices": [
      {
        "id": 178847,
        "text": "<p><span style=\"font-size:12pt;\">Pioglitazone</span></p>"
      },
      {
        "id": 178848,
        "text": "<p><span style=\"font-size:12pt;\">Pramlintide</span></p>"
      },
      {
        "id": 178849,
        "text": "<p><span style=\"font-size:12pt;\">Glimepiride</span></p>"
      },
      {
        "id": 178850,
        "text": "<p><span style=\"font-size:12pt;\">Metformin</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">Which of the following anti-diabetic drug is associated with unexplained diarrhea? (</span>INICET May 2024)</p>",
    "unique_key": "Q2470630",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264356,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Metformin</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Metformin is a biguanide that decreases hepatic glucose production and improves insulin sensitivity.&nbsp;</span></li><li><span style=\"font-size:12pt;\">It is well known to cause gastrointestinal side effects, including diarrhea, nausea, and abdominal discomfort, particularly when first starting the medication or when the dose is increased.&nbsp;</span></li><li><span style=\"font-size:12pt;\">Diarrhea is one of the most common side effects of metformin and can sometimes be severe or persistent.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>A.</strong>&nbsp;<strong>Pioglitazone</strong>: Pioglitazone is a thiazolidinedione that improves insulin sensitivity. It is not commonly associated with diarrhea. Its common side effects include weight gain, edema, and an increased risk of heart failure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>B.</strong>&nbsp;<strong>Pramlintide</strong>: Pramlintide is an amylin analog used as an adjunct treatment for diabetes. It slows gastric emptying and promotes satiety but is not typically associated with diarrhea. Nausea is a more common gastrointestinal side effect.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>C.</strong>&nbsp;<strong>Glimepiride</strong>: Glimepiride is a sulfonylurea that increases insulin secretion from the pancreas. It is not known to cause diarrhea. Hypoglycemia is its most significant side effect.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In summary, metformin is the anti-diabetic drug most commonly associated with unexplained diarrhea. The patient's symptoms are likely related to metformin use.</span></p>",
    "correct_choice_id": 178850,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7117,
    "choices": [
      {
        "id": 28436,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Safety in pregnancy</span></span></span></p>"
      },
      {
        "id": 28437,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dose adjustment in renal failure</span></span></span></p>"
      },
      {
        "id": 28438,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cost ratio from cheap to expensive</span></span></span></p>"
      },
      {
        "id": 28439,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">As per safety or therapeutic index</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Category A, B, C, D, X in drug classification is indicative of which of the following?(INICET NOV 2021)</span></span></span></p>",
    "unique_key": "Q7469157",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264357,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Safety in pregnancy</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The categories A, B, C, D, and X are used to classify drugs based on their safety during pregnancy. This classification helps in determining the potential risk of medications to the fetus when taken during pregnancy.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pregnancy drug category, which are indicative of their safety are as follows:</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Category A &gt; B &gt; C &gt; D &gt; X</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/14/screenshot-2023-12-14-165435.jpg\" style=\"height:434px; width:1000px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Dose adjustment in renal failure: </span></strong><span style=\"font-size:12.0pt\">Drug classifications for dose adjustments in renal failure typically involve guidelines based on the drug&#39;s pharmacokinetics and renal clearance. These guidelines are not categorized as A, B, C, D, X.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Cost ratio from cheap to expensive</span></strong><span style=\"font-size:12.0pt\">: Drug classifications based on cost are not typically denoted by the categories A, B, C, D, X. Cost-related classifications might be discussed in economic terms or based on generic versus brand name distinctions.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. As per safety or therapeutic index</span></strong><span style=\"font-size:12.0pt\">: The therapeutic index of a drug, which measures its safety margin, is not categorized using the A, B, C, D, X system. The therapeutic index is a ratio comparing the toxic dose to the therapeutic dose, but it is not classified in this alphabetical manner.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The classification of drugs into categories A, B, C, D, and X is specifically used to indicate their safety during pregnancy, helping healthcare providers to make informed decisions about medication use in pregnant patients.</span></span></span></p>",
    "correct_choice_id": 28436,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7119,
    "choices": [
      {
        "id": 28444,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The inhibitor can bind with any site resulting in suicidal inhibition</span></span></span></p>"
      },
      {
        "id": 28445,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The binding of the enzyme to the substrate analogue is irreversible</span></span></span></p>"
      },
      {
        "id": 28446,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">They are enzyme specific and used in rational drug design</span></span></span></p>"
      },
      {
        "id": 28447,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The inhibitor forms a product with the enzyme and the product inhibits it</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify the false statement regarding suicidal inhibition? (</span></span>INICET Nov 2021)</p>",
    "unique_key": "Q9920158",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264358,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. The inhibitor can bind with any site resulting in suicidal inhibition</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">SUICIDE INHIBTION </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Suicide inhibition, also known as mechanism-based inhibition, is a unique and fascinating aspect of enzyme kinetics. It&#39;s a process where an enzyme binds to a substrate analogue, which initially seems like a normal substrate to the enzyme. However, as the enzyme starts to act on this &#39;pseudo-substrate,&#39; a chemical reaction occurs that modifies the enzyme in such a way that it becomes irreversibly inactivated. This process is termed &#39;suicide&#39; because the enzyme actively participates in its own inhibition.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">STEPS INVOLVED IN SUICIDE INHIBITION</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ol>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Binding:</span></strong><span style=\"font-size:12.0pt\"> The suicide substrate, which is often structurally similar to the actual substrate, binds to the enzyme&#39;s active site.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Initial Reaction:</span></strong><span style=\"font-size:12.0pt\"> The enzyme catalyses a reaction on this substrate analogue, similar to how it would act on its natural substrate.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Formation of Reactive Intermediate:</span></strong><span style=\"font-size:12.0pt\"> This reaction, however, leads to the formation of a chemically reactive intermediate. This intermediate is the key to the suicide inhibition mechanism.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Modification of Enzyme:</span></strong><span style=\"font-size:12.0pt\"> The reactive intermediate then reacts with the enzyme itself, leading to a covalent modification of the enzyme. This modification typically occurs at the active site, crucial for the enzyme&#39;s activity.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Irreversible Inhibition:</span></strong><span style=\"font-size:12.0pt\"> As a result of this modification, the enzyme is irreversibly inactivated. It can no longer bind to its natural substrate or catalyse the reaction it was designed for.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Specificity:</span></strong><span style=\"font-size:12.0pt\"> One of the key features of suicide inhibition is its specificity. Because the inhibitor is structurally similar to the natural substrate, the process is highly specific to the targeted enzyme. This makes suicide inhibitors very effective as drugs, as they can selectively target and inactivate specific enzymes in the body.</span></span></span></li>\r\n</ol>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;B. The binding of the enzyme to the substrate analogue is irreversible</span></strong><span style=\"font-size:12.0pt\">: This is true. The substrate analogue binds irreversibly to the enzyme, leading to its permanent inactivation.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. They are enzyme specific and used in rational drug design</span></strong><span style=\"font-size:12.0pt\">: This is true. Suicide inhibitors are designed to be highly specific for the target enzyme, making them valuable in rational drug design.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. The inhibitor forms a product with the enzyme and the product inhibits it</span></strong><span style=\"font-size:12.0pt\">: This is true. The enzyme catalyzes the conversion of the substrate analogue to a reactive intermediate, which then irreversibly modifies the enzyme, leading to its inhibition.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">CLINICAL IMPORTANCE</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Suicide inhibitors have significant implications in drug development, especially for designing drugs that target enzymes involved in disease processes. For instance, certain antibiotics work by suicide inhibition of bacterial enzymes, and some drugs used in the treatment of hypertension and depression also act through this mechanism.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Understanding the mechanism of suicide inhibition helps in the development of more effective and specific drugs, with fewer off-target effects. It&#39;s a powerful example of how knowledge of biochemistry can be applied in medicinal chemistry and pharmacology.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">EXAMPLES OF SUICIDE INHIBITORS</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Beta lactams (Penicillins)</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Aspirin</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Allopurinol</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">MAO inhibitors</span></span></span></li>\r\n</ul>",
    "correct_choice_id": 28444,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7120,
    "choices": [
      {
        "id": 28448,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">2-10 mcg/kg/min</span></span></span></p>"
      },
      {
        "id": 28449,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">&lt; 2 mcg/kg/min</span></span></span></p>"
      },
      {
        "id": 28450,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">10-20 mcg/kg/min</span></span></span></p>"
      },
      {
        "id": 28451,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">&gt; 20 mcg/kg/min</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The dose at which dopamine acts on beta 1 receptors is:(INICET NOV 2021)</span></span></p>",
    "unique_key": "Q7967246",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264359,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. 2-10 mcg/kg/min</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">2-10 mcg/kg/min</span></strong><span style=\"font-size:12.0pt\"> is the correct dose range at which dopamine primarily acts on beta 1 receptors in the heart, enhancing cardiac output by increasing heart rate and contractility.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dopamine acts upon 3 receptors depending upon the dose:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">D1 &ndash; &lt; 2 mcg/kg/min (Present in the blood vessels of the kidney in highest concentration - Vasodilation and increased renal blood flow)</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">&beta;1 &ndash; 2-10 mcg/kg/min (Present in the heart - Increased heart rate and contractility, which improves cardiac output)</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">&alpha;1 &ndash; &gt;10 mcg/kg/min (Present in blood vessels - Vasoconstriction, which increases blood pressure).</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. &lt; 2 mcg/kg/min</span></strong><span style=\"font-size:12.0pt\">: At this dose, dopamine primarily acts on D1 receptors, causing vasodilation and increased renal blood flow without significant effects on the heart.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. 10-20 mcg/kg/min</span></strong><span style=\"font-size:12.0pt\">: At this higher dose, dopamine acts predominantly on alpha 1 receptors, causing vasoconstriction and increased blood pressure.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. &gt; 20 mcg/kg/min:</span></strong><span style=\"font-size:12.0pt\"> Similar to the previous option, at doses higher than 20 mcg/kg/min, dopamine continues to exert effects primarily on alpha 1 receptors, resulting in significant vasoconstriction.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dopamine has dose-dependent receptor selectivity. It acts on beta 1 receptors at doses of 2-10 mcg/kg/min, increasing cardiac output by enhancing heart rate and contractility.</span></span></span></p>",
    "correct_choice_id": 28448,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7122,
    "choices": [
      {
        "id": 28456,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Causes monofollicular development</span></span></span></p>"
      },
      {
        "id": 28457,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Inhibits negative feedback on GnRH</span></span></span></p>"
      },
      {
        "id": 28458,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Causes endometrial thinning</span></span></span></p>"
      },
      {
        "id": 28459,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Can be used with gonadotropins</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is the incorrect statement regarding clomiphene citrate? (INICET MAY 2021)</span></span></p>",
    "unique_key": "Q6177632",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264360,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Causes monofollicular development</span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Clomiphene citrate is SERM (Selective Estrogen Receptor Modulator) that inhibits the negative feedback of estrogen on the hypothalamus, which in turn leads to an increase in LH/FSH, and this helps in the development of multiple follicles in the ovary. Clomiphene is used in the treatment of anovulatory infertility.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Due to its anti-estrogenic action over the endometrium, it causes thickening of the cervical mucus and thinning of the endometrium.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Sometimes for ovulation induction, gonadotropins can be used with clomiphene, but it has a risk of giving rise to multiple pregnancy.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Inhibits negative feedback on GnRH: </span></strong><span style=\"font-size:12.0pt\">This statement is correct. Clomiphene citrate inhibits the negative feedback of estrogen on the hypothalamus, which increases the release of GnRH, and subsequently increases LH and FSH secretion from the pituitary gland.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Causes endometrial thinning: </span></strong><span style=\"font-size:12.0pt\">This statement is correct. Clomiphene citrate has an anti-estrogenic effect on the endometrium, which can lead to thinning of the endometrial lining, potentially impacting embryo implantation.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Can be used with gonadotropins: </span></strong><span style=\"font-size:12.0pt\">This statement is correct. Clomiphene can be used in combination with gonadotropins for ovulation induction, but this approach increases the risk of multiple pregnancies due to the stimulation of multiple follicles.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Clomiphene citrate induces ovulation by inhibiting the negative feedback of estrogen on the hypothalamus, leading to increased secretion of gonadotropins and the development of multiple follicles. It can cause endometrial thinning and can be used with gonadotropins, but it does not cause monofollicular development.</span></span></span></p>",
    "correct_choice_id": 28456,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7124,
    "choices": [
      {
        "id": 28464,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">RNA-dependent DNA polymerase inhibition</span></span></span></p>"
      },
      {
        "id": 28465,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">RNA-dependent RNA polymerase inhibition</span></span></span></p>"
      },
      {
        "id": 28466,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Fusion inhibition</span></span></span></p>"
      },
      {
        "id": 28467,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Entry inhibition</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is the mechanism of action of remdesivir? (INICET NOV 2021)</span></span></p>",
    "unique_key": "Q8234502",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264361,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B. RNA-dependent RNA polymerase inhibition</span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Remdesivir is the only FDA approved drug for COVID-19, which is recommended for moderate to severe COVID-19 patients, hospitalized patients, patients on oxygen therapy and should be used within 10 days of disease onset, after which it has no proven benefit.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It inhibits RNA-dependent RNA polymerase.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">While on treatment, monitoring of LFT, KFT and PT are required. It should be avoided in pregnant or lactating females, patients less than 12 years of age, if eGFR &lt;30ml/min or ALT&gt;5 times.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Adverse effects include anaphylaxis, nausea and infusion related reactions.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. RNA-dependent DNA polymerase inhibition:</span></strong><span style=\"font-size:12.0pt\"> This mechanism is not relevant for remdesivir. RNA-dependent DNA polymerase inhibition is associated with drugs targeting retroviruses, like reverse transcriptase inhibitors used in HIV treatment.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Fusion inhibition:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Fusion inhibitors prevent the virus from fusing with the host cell membrane, thereby blocking entry into the cell. This is not the mechanism of remdesivir. An example of a fusion inhibitor is enfuvirtide, used in HIV treatment.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Entry inhibition:</span></strong><span style=\"font-size:12.0pt\">&nbsp;Entry inhibitors block the virus from entering the host cell. This is also not the mechanism of action for remdesivir. An example of an entry inhibitor is maraviroc, which is used in HIV treatment.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Remdesivir works by inhibiting RNA-dependent RNA polymerase, thus preventing viral RNA replication in COVID-19 patients. It is important to monitor liver and kidney function during treatment and be aware of its contraindications and potential adverse effects.</span></span></span></p>",
    "correct_choice_id": 28465,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7125,
    "choices": [
      {
        "id": 28468,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ritonavir</span></span></span></p>"
      },
      {
        "id": 28469,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Vitamin C</span></span></span></p>"
      },
      {
        "id": 28470,
        "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cimetidine</span></span></span></p>"
      },
      {
        "id": 28471,
        "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ganciclovir</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Administration of which of the following drugs would increase the bioavailability of saquinavir? (INICET NOV 2021)</span></span></p>",
    "unique_key": "Q1427685",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264362,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Ritonavir</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"><br />\r\n&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Both Ritonavir and Saquinavir are Protease inhibitors that can be used in the treatment of HIV.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">They are metabolized by the hepatic CYP3A4 enzyme system. But at the same time, Ritonavir is also an inhibitor of CYP3A4. Therefore, if small doses of Ritonavir are added along with Saquinavir, it will inhibit the metabolism of Saquinavir or in other words will boost the bioavailability and concentration of Saquinavir.</span></span></span></li>\r\n</ul>",
    "correct_choice_id": 28468,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7128,
    "choices": [
      {
        "id": 28480,
        "text": "<p><span style=\"font-size:12.0pt;\">Drug A decreases intestinal absorption of Drug B</span></p>"
      },
      {
        "id": 28481,
        "text": "<p><span style=\"font-size:9pt;\">\ufeff\ufeff\ufeff</span><span style=\"font-size:12.0pt;\">Drug A reduces first pass metabolism of Drug B</span></p>"
      },
      {
        "id": 28482,
        "text": "<p><span style=\"font-size:12.0pt;\">\ufeff\ufeff\ufeffDrug A increases the metabolism of Drug B</span></p>"
      },
      {
        "id": 28483,
        "text": "<p><span style=\"font-size:12.0pt;\">Drug A increases renal elimination of Drug B</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">The table below gives the AUC of drug B alone and that of drug B when combined with another drug A. If the p value is &lt;0.01, then which of the following statements is true? (INICET 2021)</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/14/screenshot-2023-12-14-170654.jpg\" alt=\"\" width=\"700\" height=\"190\"></span></p>",
    "unique_key": "Q6184777",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264363,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B.&nbsp;Drug A reduces first pass metabolism of Drug B</strong></span><br>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The area under the curve or AUC in plasma concentration vs time graph can be used as a measure of the bioavailability of a drug. The bioavailability of a given drug refers to the fraction of the given dose which reaches the systemic circulation. The greater the area under the curve or AUC, the greater is the bioavailability.</span></li><li><span style=\"font-size:12.0pt;\">From the given data, it is seen that the AUC for Drug B is less than the AUC for Drug A + Drug B. And the p value &lt;0.01 indicates that the data is statistically significant. (As the p value is &lt;0.05)</span></li><li><span style=\"font-size:12.0pt;\">So, it can be inferred that the Drug A increases the bioavailability of drug B.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">As bioavailability depends on two factors:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Absorption (Bioavailability is directly proportional to the rate of drug absorption)</span></li><li><span style=\"font-size:12.0pt;\">First Pass Metabolism (Bioavailability is inversely proportional to the rate of first pass metabolism of the drug)</span></li><li><span style=\"font-size:12.0pt;\">Therefore, it can be assumed that drug B either increase the absorption or decrease the first pass metabolism of drug A.</span></li><li><span style=\"font-size:12.0pt;\">So among the given options, best answer seem to be option B: Drug A reduces the first pass metabolism of drug B</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Drug A decreases intestinal absorption of Drug B</strong>: This statement is incorrect. If Drug A decreased the intestinal absorption of Drug B, the AUC would be lower when the drugs are combined, not higher.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Drug A increases the metabolism of Drug B</strong>: This statement is incorrect. If Drug A increased the metabolism of Drug B, the AUC would be lower when the drugs are combined.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Drug A increases renal elimination of Drug B</strong>: This statement is incorrect. If Drug A increased the renal elimination of Drug B, it would lead to a decrease in AUC, not an increase.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The increase in the AUC of Drug B when combined with Drug A, with a statistically significant p value, indicates that Drug A reduces the first pass metabolism of Drug B, thereby increasing its bioavailability.</span></p>",
    "correct_choice_id": 28481,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "ImageBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7150,
    "choices": [
      {
        "id": 28568,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beta blockers</span></span></span></p>"
      },
      {
        "id": 28569,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Calcium channel blockers</span></span></span></p>"
      },
      {
        "id": 28570,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acetaminophen</span></span></span></p>"
      },
      {
        "id": 28571,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aspirin</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Urinary alkalinization will be most useful in toxicity of which of the following drugs? (INICET NOV 2020)</span></span></p>",
    "unique_key": "Q3639351",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264364,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. Aspirin</span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Urinary alkalinization is a key treatment in aspirin toxicity. Aspirin (salicylate) is a weak acid, and alkalinizing the urine increases the ionization of salicylates. This ionization traps salicylates in the urine, preventing their reabsorption and enhancing their elimination.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Beta blockers:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Urinary alkalinization is not a standard treatment for beta blocker toxicity. Management of beta blocker overdose typically involves supportive care and, in severe cases, specific antidotes like glucagon or high-dose insulin.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Calcium channel blockers:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Similar to beta blockers, urinary alkalinization is not a primary treatment for calcium channel blocker overdose. Treatment often includes calcium infusions, glucagon, and other supportive measures.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Acetaminophen:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> For acetaminophen toxicity, the antidote N-acetylcysteine (NAC) is used. Urinary alkalinization is not effective for acetaminophen overdose.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Urinary alkalinization is most useful in the treatment of aspirin (salicylate) toxicity because it increases the elimination of salicylates by trapping them in the urine through ionization. This method is not effective for beta blockers, calcium channel blockers, or acetaminophen toxicity.</span></span></span></p>",
    "correct_choice_id": 28571,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 7151,
    "choices": [
      {
        "id": 28572,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phase 1</span></span></span></p>"
      },
      {
        "id": 28573,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phase 3</span></span></span></p>"
      },
      {
        "id": 28574,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phase 2</span></span></span></p>"
      },
      {
        "id": 28575,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phase 4</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A hospital is investigating the effectiveness of statins in a multiple-centric clinical trial. The study involves 4000-5000 patients and half of them have received the drug while the other half was given a placebo. Both the subjects and the investigators are unaware of which group is getting the drug and which group is being administered the placebo. Which of the following phases of clinical trial corresponds to this scenario? (INICET NOV 2022)</span></span></p>",
    "unique_key": "Q9781682",
    "question_audio": null,
    "question_video": null,
    "map_id": 33264365,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Phase 3 </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;</span></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">As the study is being conducted in multiple centers in a double blinded manner, where neither the physician nor the patients know what they are receiving, therefore this trial is in Phase 3.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The phases of clinical trials are as follows: -</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/22/screenshot-2024-07-22-103816.png\" style=\"height:426px; width:1000px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phase Zero trials are called micro-dosing studies. It is an optional trial done by some companies on small number of healthy volunteers to know the pharmacokinetics of the drug. Dose used is one-hundredth of the final human dose or 100 microgram (whichever is lower).</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pre-clinical trials are animal studies. The drugs are first tested on the small animals like rats, guinea pig etc. to know the complete pharmacokinetics.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The described clinical trial, with its large sample size, multiple centers, double-blind design, and focus on confirming the efficacy of statins, corresponds to a <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phase 3</span></strong> clinical trial. This phase is crucial for determining whether the drug is effective and safe for widespread use.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>",
    "correct_choice_id": 28573,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  }
];
        let quizName = 'Late Night Pyq (Inicet, Pharmacology-1)';
        const quizFilename = 'late-night-pyq-inicet-pharmacology-1-222414fc.html';
        let hierarchy = ["Cerebellum", "Mock Test", "Late Night PYQ (INICET)"];
        
        // Handle Custom Quiz Loading
        if (window.location.pathname.endsWith('custom_quiz.html')) {
            const customData = JSON.parse(localStorage.getItem('customQuizData'));
            if (customData) {
                questionsData = customData.questions;
                quizName = customData.name;
                hierarchy = customData.hierarchy;
                document.title = quizName + ' - Brain And Scalpel';
                document.getElementById('totalQuestions').textContent = questionsData.length;
                document.getElementById('quizHierarchy').textContent = hierarchy.join(' > ');
            }
        }

        let currentQuestionIndex = 0;
        let selectedOption = null;
        let currentMode = 'study';
        let timer = null;
        let timeRemaining = 0;
        let questionStartTime = Date.now();
        let quizStartTime = Date.now();
        let isQuizCompleted = false;
        
        let questionStates = new Array(questionsData.length).fill(null).map(() => ({
            status: 'not_attempted',
            bookmarked: false,
            markedForReview: false,
            selectedAnswer: null,
            timeSpent: 0
        }));
        
        let stats = {
            correctAnswers: 0,
            incorrectAnswers: 0,
            totalAttempted: 0,
            totalTime: 0,
            notAttempted: questionsData.length
        };

        // --- NEW: History Management ---
        function saveProgress() {
            if (isQuizCompleted) return; // Don't save after completion
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            userHistory[quizFilename] = {
                questionStates,
                stats,
                currentQuestionIndex,
                currentMode,
                status: 'incomplete',
                lastSeen: new Date().toISOString()
            };
            localStorage.setItem('userHistory', JSON.stringify(userHistory));
        }

        function loadProgress() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            const savedState = userHistory[quizFilename];
            if (savedState) {
                questionStates = savedState.questionStates;
                stats = savedState.stats;
                currentQuestionIndex = savedState.currentQuestionIndex;
                currentMode = savedState.currentMode;
                console.log('Progress loaded.');
                return true;
            }
            return false;
        }

        function clearProgress() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            if(userHistory[quizFilename]) {
                delete userHistory[quizFilename];
                localStorage.setItem('userHistory', JSON.stringify(userHistory));
                console.log('Previous progress cleared.');
            }
        }

        function markQuizAsCompleted() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            const totalQuestions = questionsData.length;
            const correct = stats.correctAnswers || 0;
            
            userHistory[quizFilename] = {
                score: correct,
                total: totalQuestions,
                status: 'completed',
                completedOn: new Date().toISOString()
            };
            localStorage.setItem('userHistory', JSON.stringify(userHistory));
        }
        // --- End of History Management ---

        const urlParams = new URLSearchParams(window.location.search);
        const startAt = parseInt(urlParams.get('startAt'));
        const resume = urlParams.get('resume') === 'true';

        function goBack() {
            if (!isQuizCompleted) saveProgress(); // Save progress before leaving
            window.location.href = document.referrer || 'index.html';
        }

        function selectMode(mode) {
            currentMode = mode;
            document.getElementById('modeModal').style.display = 'none';
            initializeQuiz();
        }

        function initializeQuiz() {
            quizStartTime = Date.now();
            
            const bookmarkBtn = document.getElementById('bookmarkBtn');
            const markReviewBtn = document.getElementById('markReviewBtn');
            const testModeReviewLegend = document.getElementById('testModeReviewLegend');
            const isTestMode = currentMode === 'test' || currentMode === 'timed_exam';
            
            document.getElementById('statsBar').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('studyModeLegend').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('testModeLegend').style.display = isTestMode ? 'block' : 'none';
            document.getElementById('submitSection').style.display = isTestMode ? 'block' : 'none';
            bookmarkBtn.style.display = isTestMode ? 'none' : 'flex';
            markReviewBtn.style.display = isTestMode ? 'flex' : 'none';
            testModeReviewLegend.style.display = isTestMode ? 'flex' : 'none';
            
            if (currentMode === 'timed_study' || currentMode === 'timed_exam') {
                document.getElementById('timerContainer').classList.remove('hidden');
            }
            
            if (!isNaN(startAt) && startAt >= 0 && startAt < questionsData.length) {
                currentQuestionIndex = startAt;
            }

            loadBookmarkedQuestions();
            generateQuestionNav();
            updateStats();
            displayQuestion();
        }

        function generateQuestionNav() {
            const nav = document.getElementById('questionNav');
            nav.innerHTML = '';
            
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.createElement('button');
                btn.textContent = i + 1;
                btn.className = 'w-8 h-8 text-sm font-medium rounded transition-all duration-200';
                btn.onclick = () => jumpToQuestion(i);
                btn.id = `navBtn_${i}`;
                nav.appendChild(btn);
            }
            
            updateQuestionNav();
        }

        function updateQuestionNav() {
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.getElementById(`navBtn_${i}`);
                const state = questionStates[i];
                let className = '';
                
                if (i === currentQuestionIndex) {
                    className = 'nav-btn-current';
                } else if (state.bookmarked) {
                    className = 'nav-btn-bookmarked';
                } else if (state.markedForReview) {
                    className = 'nav-btn-marked-review';
                } else if (currentMode === 'study' || currentMode === 'timed_study') {
                    if (state.status === 'correct') className = 'nav-btn-correct';
                    else if (state.status === 'incorrect') className = 'nav-btn-incorrect';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                } else {
                    if (state.selectedAnswer !== null) className = 'nav-btn-answered';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                }
                btn.className = `w-8 h-8 text-sm font-medium rounded ${className}`;
            }
        }

        function jumpToQuestion(index) {
            if (index >= 0 && index < questionsData.length) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex = index;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            }
        }

        function updateStats() {
            if (currentMode === 'study' || currentMode === 'timed_study') {
                document.getElementById('correctCount').textContent = stats.correctAnswers;
                document.getElementById('incorrectCount').textContent = stats.incorrectAnswers;
                document.getElementById('totalAttempted').textContent = stats.totalAttempted;
                
                const accuracy = stats.totalAttempted > 0 
                    ? Math.round((stats.correctAnswers / stats.totalAttempted) * 100)
                    : 0;
                document.getElementById('accuracy').textContent = accuracy + '%';
                
                stats.totalTime = questionStates.reduce((acc, state) => acc + state.timeSpent, 0);
                const timeSpent = Math.floor(stats.totalTime / 1000);
                const minutes = Math.floor(timeSpent / 60);
                const seconds = timeSpent % 60;
                document.getElementById('timeSpent').textContent = 
                    minutes + ':' + seconds.toString().padStart(2, '0');
            }
        }

        function setupVideo(videoElement, url) {
            if (Hls.isSupported()) {
                const hls = new Hls();
                hls.loadSource(url);
                hls.attachMedia(videoElement);
            } else if (videoElement.canPlayType('application/vnd.apple.mpegurl')) {
                videoElement.src = url;
            }
        }

        function displayQuestion() {
            if (!questionsData || questionsData.length === 0) {
                document.getElementById('questionText').innerHTML = 'No questions available for this quiz.';
                return;
            };
            
            const question = questionsData[currentQuestionIndex];
            questionStartTime = Date.now();
            
            selectedOption = questionStates[currentQuestionIndex].selectedAnswer;
            
            const progress = ((currentQuestionIndex + 1) / questionsData.length) * 100;
            document.getElementById('progressBar').style.width = progress + '%';
            document.getElementById('currentQuestion').textContent = currentQuestionIndex + 1;
            updateQuestionNav();
            
            document.getElementById('prevBtn').disabled = currentQuestionIndex === 0;
            
            document.getElementById('solutionContainer').classList.add('hidden');
            
            document.getElementById('questionText').innerHTML = question.text || 'No question text available';
            
            let mediaHtml = '';
            if (question.question_audio) mediaHtml += `<div class="glass-light p-4 mb-4"><audio src="${question.question_audio}" controls class="w-full"></audio></div>`;
            if (question.question_video) mediaHtml += `<div class="glass-light p-4 mb-4"><video src="${question.question_video}" controls class="w-full rounded-lg"></video></div>`;
            if (question.question_images) {
                question.question_images.forEach(imgSrc => {
                    if (imgSrc) mediaHtml += `<div class="glass-light p-4 mb-4"><img src="${imgSrc}" alt="Question Image" class="w-full rounded-lg"></div>`;
                });
            }
            document.getElementById('questionMedia').innerHTML = mediaHtml;
            
            const optionsContainer = document.getElementById('optionsContainer');
            optionsContainer.innerHTML = '';
            optionsContainer.classList.remove('answered');
            
            if (question.choices && Array.isArray(question.choices)) {
                question.choices.forEach((choice, index) => {
                    const optionLetter = String.fromCharCode(65 + index);
                    const isSelected = selectedOption === index;
                    
                    const optionDiv = document.createElement('div');
                    optionDiv.innerHTML = `
                        <button type="button" class="option-button ${isSelected ? 'selected' : ''}" data-option-index="${index}">
                            <div class="option-letter">${optionLetter}</div>
                            <div class="option-text">${choice.text || 'Option ' + (index + 1)}</div>
                        </button>
                    `;
                    optionsContainer.appendChild(optionDiv);
                });
                
                optionsContainer.addEventListener('click', function(e) {
                    const optionButton = e.target.closest('.option-button');
                    if (optionButton) {
                        const optionIndex = parseInt(optionButton.getAttribute('data-option-index'));
                        selectOption(optionIndex);
                    }
                });
            }
            
            updateBookmarkButton();
            updateMarkReviewButton();

            if ((currentMode === 'timed_study' || currentMode === 'timed_exam') && !isQuizCompleted) {
                startTimer();
            }
        }

        function selectOption(index) {
            const optionsContainer = document.getElementById('optionsContainer');
            if (optionsContainer.classList.contains('answered')) return;

            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                questionStartTime = Date.now();
            }
            
            selectedOption = index;
            questionStates[currentQuestionIndex].selectedAnswer = index;
            
            document.querySelectorAll('.option-button').forEach((btn, i) => {
                btn.classList.toggle('selected', i === index);
            });
            
            if (currentMode === 'study' || currentMode === 'timed_study') {
                processAnswer();
            } else {
                if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                    questionStates[currentQuestionIndex].status = 'answered';
                    stats.totalAttempted++;
                    stats.notAttempted--;
                }
                updateQuestionNav();
            }
            saveProgress(); // NEW: Save on navigation
        }

        function processAnswer() {
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            
            if(selectedOption === null) return;

            const selectedChoice = question.choices[selectedOption];
            const isCorrect = selectedChoice.id === correctChoiceId;
            
            if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                stats.totalAttempted++;
                stats.notAttempted--;
                if(isCorrect) stats.correctAnswers++; else stats.incorrectAnswers++;
            }
            questionStates[currentQuestionIndex].status = isCorrect ? 'correct' : 'incorrect';
            
            updateStats();
            showInlineFeedback(isCorrect);
            updateQuestionNav();
        }

        function showInlineFeedback(isCorrect) {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;

            const optionsContainer = document.getElementById('optionsContainer');
            const optionButtons = optionsContainer.querySelectorAll('.option-button');
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            let correctOptionIndex = question.choices.findIndex(c => c.id === correctChoiceId);

            optionsContainer.classList.add('answered');

            optionButtons.forEach((btn, index) => {
                btn.classList.remove('selected');
                if (index === correctOptionIndex) btn.classList.add('correct');
                else if (index === selectedOption && !isCorrect) btn.classList.add('incorrect');
            });

            showSolution();
        }


        function showSolution() {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;
            
            const question = questionsData[currentQuestionIndex];
            document.getElementById('solutionText').innerHTML = question.solution || 'No solution provided';
            
            const videoContainer = document.getElementById('solutionVideo');
            const videoPlayer = document.getElementById('explanationVideoPlayer');
            const explanationVideo = question.explanation_video;
            
            if (explanationVideo) {
                videoContainer.classList.remove('hidden');
                if (explanationVideo.includes('.m3u8')) setupVideo(videoPlayer, explanationVideo);
                else videoPlayer.src = explanationVideo;
            } else {
                videoContainer.classList.add('hidden');
            }

            const audioContainer = document.getElementById('solutionAudio');
            audioContainer.innerHTML = '';
            if (question.explanation_audio_eng) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English Explanation:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
            }
            if (question.explanation_audio_hin) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish Explanation:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;
            }
            
            const imagesContainer = document.getElementById('solutionImages');
            imagesContainer.innerHTML = '';
            if (question.explanation_images) {
                 question.explanation_images.forEach(imgSrc => {
                    if(imgSrc) imagesContainer.innerHTML += `<div class="mt-4"><img src="${imgSrc}" alt="Explanation Image" class="w-full rounded-lg"></div>`;
                });
            }

            document.getElementById('solutionContainer').classList.remove('hidden');
        }

        function submitQuiz() {
            if (timer) clearInterval(timer);
            if (!confirm('Are you sure you want to submit the quiz?')) return;
            
            isQuizCompleted = true;
            let correct = 0, incorrect = 0;
            const totalTime = Date.now() - quizStartTime;
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                if (state.selectedAnswer !== null) {
                    if (question.choices[state.selectedAnswer].id === question.correct_choice_id) {
                        correct++;
                        state.status = 'correct';
                    } else {
                        incorrect++;
                        state.status = 'incorrect';
                    }
                }
            });
            
            // Save performance data
            const performanceData = JSON.parse(localStorage.getItem('quizPerformanceData')) || [];
            performanceData.push({
                quizName: quizName,
                hierarchy: hierarchy,
                timestamp: Date.now(),
                totalTime: totalTime,
                stats: {
                    correct: correct,
                    incorrect: incorrect,
                    notAttempted: questionsData.length - (correct + incorrect)
                }
            });
            localStorage.setItem('quizPerformanceData', JSON.stringify(performanceData));

            stats.correctAnswers = correct; // Update global stats
            stats.incorrectAnswers = incorrect;
            markQuizAsCompleted(); // NEW: Mark quiz as complete in history
            showPerformanceAnalysis(correct, incorrect, questionsData.length - (correct + incorrect), totalTime);
        }

        function showPerformanceAnalysis(correct, incorrect, notAttempted, totalTime) {
            const modal = document.getElementById('performanceModal');
            const accuracy = (correct + incorrect) > 0 ? Math.round((correct / (correct + incorrect)) * 100) : 0;
            
            const circumference = 2 * Math.PI * 65;
            const scoreCircle = document.getElementById('scoreCircle');
            scoreCircle.style.strokeDasharray = `${circumference} ${circumference}`;
            scoreCircle.style.strokeDashoffset = circumference - (accuracy / 100) * circumference;
            
            document.getElementById('accuracyScore').textContent = `${accuracy}%`;
            document.getElementById('totalQuestionsResult').textContent = questionsData.length;
            document.getElementById('correctResult').textContent = correct;
            document.getElementById('incorrectResult').textContent = incorrect;
            document.getElementById('notAttemptedResult').textContent = notAttempted;
            
            const totalMinutes = Math.floor(totalTime / 60000);
            const totalSeconds = Math.floor((totalTime % 60000) / 1000);
            document.getElementById('totalTimeResult').textContent = `${totalMinutes}:${totalSeconds.toString().padStart(2, '0')}`;
            
            const avgTime = totalTime / questionsData.length;
            const avgMinutes = Math.floor(avgTime / 60000);
            const avgSeconds = Math.floor((avgTime % 60000) / 1000);
            document.getElementById('avgTimeResult').textContent = `${avgMinutes}:${avgSeconds.toString().padStart(2, '0')}`;
            
            modal.classList.remove('hidden');
        }

        function closePerformanceModal() { document.getElementById('performanceModal').classList.add('hidden'); }

        function reviewQuestions() {
            document.getElementById('questionReviewSection').classList.remove('hidden');
            const container = document.getElementById('reviewQuestionsContainer');
            container.innerHTML = '';
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                const correctChoiceId = question.correct_choice_id;
                
                let statusClass = 'not-attempted', statusText = 'Not Attempted';
                if (state.selectedAnswer !== null) {
                    const selectedChoice = question.choices[state.selectedAnswer];
                    if (selectedChoice.id === correctChoiceId) { statusClass = 'correct'; statusText = 'Correct'; }
                     else { statusClass = 'incorrect'; statusText = 'Incorrect'; }
                }
                
                const reviewDiv = document.createElement('div');
                reviewDiv.className = `review-question ${statusClass}`;
                
                let optionsHtml = (question.choices || []).map((choice, choiceIndex) => {
                    const isSelected = state.selectedAnswer === choiceIndex;
                    const isCorrect = choice.id === correctChoiceId;
                    let borderClass = 'border-gray-600';
                    if(isCorrect) borderClass = 'border-green-500';
                    else if(isSelected) borderClass = 'border-red-500';
                    
                    return `<div class="p-3 rounded-lg border ${borderClass}"><span class="font-bold mr-3">${String.fromCharCode(65 + choiceIndex)}</span><span>${choice.text}</span></div>`;
                }).join('');

                const videoHtml = question.explanation_video ? `<div class="mt-4"><video id="review-video-${index}" data-src="${question.explanation_video}" class="w-full rounded-lg" controls></video></div>` : '';
                
                let audioHtml = '';
                if(question.explanation_audio_eng) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
                if(question.explanation_audio_hin) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;

                let imagesHtml = (question.explanation_images || []).map(src => src ? `<div class="mt-4"><img src="${src}" alt="Explanation Image" class="w-full rounded-lg"></div>` : '').join('');

                reviewDiv.innerHTML = `
                    <div class="mb-4">
                        <div class="flex justify-between items-center mb-3">
                            <h4 class="text-lg font-bold text-white">Question ${index + 1}</h4>
                            <span class="text-sm px-3 py-1 rounded-full bg-${statusClass === 'correct' ? 'green' : statusClass === 'incorrect' ? 'red' : 'gray'}-600 text-white">${statusText}</span>
                        </div>
                        <div class="text-white mb-4">${question.text}</div>
                    </div>
                    <div class="space-y-2 mb-4">${optionsHtml}</div>
                    <div class="bg-green-900 bg-opacity-20 p-4 rounded-lg border border-green-700">
                        <h5 class="text-green-400 font-bold mb-2">Explanation:</h5>
                        <div class="text-white text-opacity-90">${question.solution || 'No solution available.'}</div>
                        ${videoHtml}
                        ${audioHtml}
                        ${imagesHtml}
                    </div>`;
                container.appendChild(reviewDiv);
            });
            initializeReviewVideos();
        }

        function initializeReviewVideos() {
            document.querySelectorAll('video[data-src]').forEach(videoEl => {
                const src = videoEl.dataset.src;
                if (src && src.includes('.m3u8')) {
                    setupVideo(videoEl, src);
                } else if (src) {
                    videoEl.src = src;
                }
            });
        }

        function retakeQuiz() {
            if (confirm('Are you sure you want to retake the quiz? This will reset all your answers.')) {
                if (window.location.pathname.endsWith('custom_quiz.html')) {
                    localStorage.removeItem('customQuizData');
                }
                clearProgress(); // NEW: Clear history on retake
                location.reload();
            }
        }

        function loadBookmarkedQuestions() {
            const bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            bookmarks.forEach(bookmark => {
                if (bookmark.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-'))) {
                    if (bookmark.questionIndex < questionsData.length) {
                        questionStates[bookmark.questionIndex].bookmarked = true;
                    }
                }
            });
        }

        function toggleBookmark() {
            const isBookmarked = !questionStates[currentQuestionIndex].bookmarked;
            questionStates[currentQuestionIndex].bookmarked = isBookmarked;
            
            let bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            
            if (isBookmarked) {
                const bookmarkData = {
                    quizName: quizName,
                    quizFile: window.location.pathname.split('/').pop(),
                    questionIndex: currentQuestionIndex,
                    question: questionsData[currentQuestionIndex],
                    hierarchy: hierarchy,
                    timestamp: Date.now()
                };
                bookmarks.push(bookmarkData);
            } else {
                bookmarks = bookmarks.filter(b => 
                    !(b.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-')) && b.questionIndex === currentQuestionIndex)
                );
            }
            
            localStorage.setItem('bookmarkedQuestions', JSON.stringify(bookmarks));
            updateBookmarkButton();
            updateQuestionNav();
        }

        function updateBookmarkButton() {
            const btn = document.getElementById('bookmarkBtn');
            const text = document.getElementById('bookmarkText');
            const isBookmarked = questionStates[currentQuestionIndex].bookmarked;
            
            btn.className = isBookmarked ? 'gradient-yellow px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isBookmarked ? 'Bookmarked' : 'Bookmark';
        }
        
        function toggleMarkForReview() {
            questionStates[currentQuestionIndex].markedForReview = !questionStates[currentQuestionIndex].markedForReview;
            updateMarkReviewButton();
            updateQuestionNav();
        }

        function updateMarkReviewButton() {
            const btn = document.getElementById('markReviewBtn');
            const text = document.getElementById('markReviewText');
            const isMarked = questionStates[currentQuestionIndex].markedForReview;
            
            btn.className = isMarked ? 'gradient-purple px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isMarked ? 'Marked' : 'Mark for Review';
        }

        function previousQuestion() {
            if (currentQuestionIndex > 0) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex--;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            }
        }

        function nextQuestion() {
            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
            }
            
            if (currentQuestionIndex < questionsData.length - 1) {
                currentQuestionIndex++;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            } else {
                if (currentMode === 'test' || currentMode === 'timed_exam') {
                    if (confirm('You have reached the end of the quiz. Would you like to submit your answers now?')) {
                        submitQuiz();
                    }
                } else {
                    if (confirm('You have completed all questions. Would you like to review from the beginning?')) {
                        currentQuestionIndex = 0;
                        displayQuestion();
                        saveProgress();
                    }
                }
            }
        }

        function startTimer() {
            if (timer) clearInterval(timer);
            timeRemaining = 120; // 2 minutes per question
            updateTimerDisplay();
            
            timer = setInterval(() => {
                timeRemaining--;
                updateTimerDisplay();
                
                if (timeRemaining <= 0) {
                    clearInterval(timer);
                    if (currentMode === 'timed_exam') {
                        submitQuiz();
                    } else {
                        nextQuestion();
                    }
                }
            }, 1000);
        }

        function updateTimerDisplay() {
            const minutes = Math.floor(timeRemaining / 60);
            const seconds = timeRemaining % 60;
            document.getElementById('timeDisplay').textContent = 
                minutes + ':' + seconds.toString().padStart(2, '0');
        }

        function toggleSidebar() {
            document.getElementById('quizSidebar').classList.toggle('open');
        }

        document.addEventListener('DOMContentLoaded', () => {
             if (resume) {
                if (loadProgress()) {
                    document.getElementById('modeModal').style.display = 'none';
                    initializeQuiz(); // Resume directly into the saved mode and state
                } else {
                    // If resume fails (e.g., cleared history), start fresh
                    clearProgress();
                    document.getElementById('modeModal').style.display = 'flex';
                }
             } else if (!window.location.pathname.endsWith('custom_quiz.html')) {
                clearProgress(); // Clear old progress if not resuming
                document.getElementById('modeModal').style.display = 'flex';
             } else {
                initializeQuiz();
             }
        });
        
        document.addEventListener('keydown', function(e) {
            if (document.getElementById('modeModal').style.display !== 'none') return;
            if (document.getElementById('performanceModal').classList.contains('hidden') === false) return;
            
            if (e.key >= '1' && e.key <= '4') {
                const optionIndex = parseInt(e.key) - 1;
                const options = document.querySelectorAll('.option-button');
                if (optionIndex < options.length) selectOption(optionIndex);
            } else if (e.key === 'ArrowLeft') {
                previousQuestion();
            } else if (e.key === 'ArrowRight' || e.key === ' ') {
                e.preventDefault();
                nextQuestion();
            } else if (e.key.toLowerCase() === 'b' && (currentMode === 'study' || currentMode === 'timed_study')) {
                toggleBookmark();
            } else if (e.key.toLowerCase() === 'm' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                toggleMarkForReview();
            } else if (e.key.toLowerCase() === 's' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                submitQuiz();
            }
        });
    </script>
</body>
</html>